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Summary 
Background: Vitamin D deficiency is one of the most commonly under diagnosed 
micronutrient deficiencies in the world. Both animal and human studies suggest that 
vitamin D plays an important role in innate and adaptive immunity, erythropoiesis and 
neurodevelopment, in addition to its osteoblastic activities.   
Objectives: To estimate the associations between vitamin D  status in early childhood 
and i) acute lower respiratory tract infections, clinical pneumonia, diarrhea, anemia, 
neurodevelopment and physical growth in early childhood; ii) neurodevelopment and 
physical growth in school age.  
Methods: We used data from a randomized placebo controlled trial among 1000 North 
Indian children 6-30 months of age and a follow up study conducted when the children 
were between 6-9 years. A quantitative electrochemiluminescence-binding assay was 
used to measure the plasma concentration of vitamin D. We used multivariable 
regressions to examine the association between vitamin D status and episodes of acute 
lower respiratory tract infections (ALRIs), clinical pneumonia, diarrhea, hemoglobin, 
anemia, neurodevelopment and growth.  
Results: The prevalence of vitamin D deficiency (<10 ng/mL) was 34.5% when the 
children were 6-30 months old. The risk of ALRIs (OR 1.26; 95% CI: 1.03 to 1.55) and 
moderate anemia (RR 1.58; 95% CI: 1.09 to 2.31) was significantly higher among 
vitamin D deficient children than among non-deficient children. There were no 
significant differences in any of the cognitive outcomes and linear growth between 
vitamin D deficient and non-deficient children either during early childhood or at school 
age.  
Conclusions: Our results imply that vitamin D is one of the critical micronutrients for the 
prevention of ALRIs and anemia during early childhood, but it has a negligible role in 
neurodevelopment and growth in this population.  
Consequences: The protective role of vitamin D on ALRIs and anemia needs to be 
confirmed in randomized controlled trials targeting vitamin D deficient children.  
                                                                                                                                                                                     9 
 




Chowdhury R, Taneja S, Bhandari N, Sinha B, Upadhyay RP, Bhan M, Strand TA. 
Vitamin D deficiency predicts infections in Young North Indian Children: a secondary 
data analysis. PLOS ONE 2017; 12(3): e0170509 
 
Paper-II 
   
Chowdhury R, Taneja S, Bhandari N, Strand TA, Bhan MK. Vitamin D deficiency, and 
mild to moderate anemia in young North Indian children: a secondary data analysis. 




Chowdhury R, Taneja S, Bhandari N, Kvestad I, Strand TA, Bhan MK. Vitamin D status, 
and neurodevelopment, and growth in young North Indian children: a secondary data 





Chowdhury R, Taneja S, Kvestad I, Hysing M, Bhandari N, Strand TA. Vitamin D status 
in early childhood is not associated with cognitive development, and linear growth at 6-9 











   
  




Vitamin D belongs to the group of fat-soluble vitamins. Vitamin D3 and vitamin D2 are 
essential compounds in the vitamin D group. Vitamin D is primarily produced in the skin 
after exposure to ultraviolet B (UVB) radiation. Thus, a significant cause of vitamin D 
deficiency is inadequate exposure to sunlight. Other factors contributing to vitamin D 
deficiency are atmospheric pollution, dark skin,  and low vitamin D from dietary intake 
(1). Vitamin D deficiency is common among children in the Indian subcontinent (2).  
Vitamin D increases intestinal absorption of calcium, magnesium, and phosphate (3). The 
Vitamin D receptor (VDR), a member of the steroid hormone receptor superfamily, is 
present in the intestines, bones, kidney, respiratory epithelium, and brain (4). The VDR 
primarily plays a role in the phosphorylation of 1, 25-dihydroxyvitamin D (1, 25 (OH)2 
D). Vitamin D exerts many effects on innate and adaptive immunity, hematopoiesis, and 
development through the VDR (5). Animal models and observational studies have 
suggested that vitamin D deficiency causes respiratory tract infections, anemia, and 
impaired neurocognitive development (6-8). Thus, delineating skeletal and extra-skeletal 
roles of vitamin D is essential. Currently, vitamin D supplementation is recommended in 
infants and children to improve their bone health (9). However, it is not recommended for 
prevention of common infections, such as respiratory tract infections, or anemia or 
impaired neurodevelopment. 
 
Vitamin D metabolism 
 
Vitamin D exists in two primary nutritionally relevant chemical forms, vitamin D2 
(ergocalciferol) and vitamin D3 (cholecalciferol) (10). Vitamin D3 is produced in the 
skin of vertebrates on exposure to UVB radiation, whereas vitamin D2 is produced from 
the precursor ergosterol by phytoplankton, yeast, invertebrates, and fungi in response to 
UV radiation (10). 
Vitamin D synthesis begins in the stratum basale and stratum spinosum, the innermost 
layers of the skin. In the skin, 7-dehydrocholesterol (7-DHC), a precursor of cholesterol, 
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absorbs UVB radiation on exposure to sunlight. It transforms into previtamin D3, which 
undergoes thermal isomerization to form vitamin D3 at average body temperature (11). 
This thermal isomerization facilitates the translocation of vitamin D3 from the skin to the 
blood circulation. In the blood circulation, vitamin D3 is bound to vitamin D binding 
protein (VDBP) (12). The VDBP bound vitamin D3 is transported to the liver and 
hydroxylated to form 25-hydroxycholecalciferol (25(OH)D) by hepatic 25-hydroxylase. 
Hepatic 25-hydroxylase is a mitochondrial and microsomal enzyme encoded by the 
CYP2R1 gene (11). Further, mitochondrial 25-hydroxyvitamin D-1α-hydroxylase, 
encoded by CYP27B1 gene in the kidney, converts 25(OH)D to 1, 25 (OH)2 D (11). The 
parathyroid hormone (PTH) stimulates the expression of the CYP27B1 gene (13). 
 
Biological actions of vitamin D 
 
1,25(OH)2D is the biologically active form of vitamin D (14). One of the critical 
functions of 1,25(OH)2D is to maintain plasma concentration of calcium within a 
physiological range by increasing calcium absorption from the intestine (11). It also 
increases intestinal phosphorus absorption and induces the formation and activation of 
osteoclasts and reabsorption of calcium from the distal renal tubule using PTH. Thus, 
1,25(OH)2D acts on the intestines, bones, and kidneys to elevate plasma calcium (Figure 
1) for mineralization of the bone and many other biological actions (11).  
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Genomic actions of vitamin D 
 
The VDR is a member of the steroid hormone receptor superfamily (4). VDRs are present 
in the tissues of the intestine, bone, kidney, respiratory epithelium, and brain (15). They 
exhibit high affinity for 1,25(OH)2D. 1,25(OH)2D is phosphorylated after binding to 
VDR and then it is taken by one of the three 9-cis retinoid X receptors (RXRα, RXRβ, 
and RXRγ) (16). The combination of VDR, RXR and 1,25(OH)2D interacts with 
coregulatory proteins and regulates the transcription of vitamin D responsive elements 
(VDREs). VDREs are present in the genes involved in a diverse range of processes, 
including the regulation of cell proliferation, differentiation, and apoptosis (17). 
Osteocalcin, osteopontin, and alkaline phosphatase are few of the best characterized gene 
products that are induced by 1,25(OH)2D in osteoblasts (18). The epithelial calcium 
channel protein (CaT1) is the dominant gene product induced by 1,25 (OH)2D in the 
small intestine. CaT1 directly affects the entry of calcium into intestinal cells. 
1,25(OH)2D induces the expression of the regulator gene and proto-oncogene products 
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Nongenomic actions of vitamin D 
 
The nongenomic actions of 1,25(OH)2D are independent of receptor-mediated 
transcription (20). One of the critical nongenomic actions of 1,25(OH)2D is the induction 
of rapid intestinal absorption of calcium called transcaltachia (20). Transcaltachia leads to 
the activation of multiple signaling cascades, such as the phosphorylation of protein 
kinase C, the opening of cellular calcium channels increasing the intracellular calcium 
uptake, and further activation of mitogen-activated protein kinase pathways (20). 
 
VDR: Vitamin D receptor; RXR: cis-retinoid; VDRE: vitamin D–responsive elements; CaT1: calcium channel 
protein; CaBP: Calcium binding protein; 24-OH-ase: 24-hydroxylase; Alk Pase: Alkaline Phosphatase; c-myc, c-
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Role of vitamin D in immunity  
 
Vitamin D modulates various immune functions of different cell types, such as 
monocytes, lymphocytes, and epithelial cells, through its biologically active form 




Innate immunity is the first line of defense against microbes in the body. Innate immune 
response to microbial invasion involves the complement system and antibacterial 
responses by neutrophils and macrophages (21). The role of vitamin D in innate 
immunity can be traced back to reports regarding tuberculosis treatment with cod liver 
oil, which is a source of vitamin D (22). Vitamin D levels have been reported to be 
significantly lower in septic shock patients and are associated with lower concentration of 
antimicrobial protein cathelicidin (23). It supports the hypothesis that the vitamin D 
status regulates antimicrobial protein levels. 
Vitamin D enhances chemotaxis and phagocytic capabilities of innate immune cells (24). 
Vitamin D, VDR, and RXR activate the transcription of antimicrobial peptides, such as 
defensin β2 and human cathelicidin antimicrobial peptide (hCAP18) (25). The 1α-
hydroxylase and VDR recognize pathogens through toll-like receptors and modulate the 
gene expression for cathelicidin production. (25) hCAP18 is cleaved from LL-37 (a 37-
residue active cationic peptide) and destabilizes microbial membranes (26). 
Vitamin D exerts immune-modulatory effects on monocytes and other innate antigen-
presenting cells, particularly dendritic cells (DC). It can alter the function and 
morphology of DC to induce a more tolerogenic immature state (27). Vitamin D also 









Vitamin D suppresses adaptive immunity (28). It suppresses immune responses mediated 
by Type 1 T helper (Th1) cells. Th1 cells produce inflammatory cytokines, such as IL-2 
and interferon gamma (IFNγ) (29). Suppressive actions on IL-2 result in the blocking of 
NFAT/AP-1 complex formation and sequestrating of Runx1 (The Runx1 gene translates 
to the protein runt-related transcription factor 1) (30). 1,25(OH)2D directly binds the 
VDR/RXR to negative VDREs in the IFNγ promoter (17). Vitamin D enhances cytokines 
associated with Type 2 T helper (Th2) cells and shifts the expression of a Th1 based 
response toward a Th2 based response (31). 
Vitamin D induces regulatory T (Treg) cells (cells that are important for the inhibition of 
inflammation) through the induction of Foxp3 (the transcription factor involved in the 
development and function of Treg cells) and downregulates Th17-producing cells (32). 
The effects of vitamin D on IL-17 include the following mechanisms: blocking Nuclear 
factor of activated T-cells (NFAT), Runx1 binding to the IL-17 promoter, and the 
induction of Foxp3 (30). Vitamin D suppresses IL-17 through the inhibition of the 
transcription factor RORγt, which leads to Th17 cell differentiation (33); furthermore, it 
inhibits the DC differentiation, suppressing the proinflammatory cytokine IL-12 and 
increasing IL-10, an anti-inflammatory cytokine produced by Th2 cells (34). 
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TLR2: Toll-like receptor 2; TLR4: Toll-like receptor 2; IgM: Immunoglobulin M; IgG: Immunoglobulin G; 
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Role of vitamin D in anemia 
 
Existing evidence suggests that vitamin D deficiency increases the risk of anemia by 
upregulating proinflammatory cytokines, decreasing iron availability, and decreasing 
erythropoiesis (Figure 4). 
 
Inflammation and Hepcidin 
 
Vitamin D concentration and anemia are associated through the direct suppression of 
hepcidin messenger Ribonucleic Acid  (mRNA) expression by vitamin D and a reduction 
of hepcidin-stimulatory proinflammatory cytokines (8). 
Hepcidin is a peptide hormone secreted predominantly by hepatocytes. It binds to and 
causes degradation of the iron-efflux transporter ferroportin. This process leads to iron 
retention within these cells, resulting in decreased intestinal iron absorption and 
decreased iron recycling from macrophages; this aberration can result in iron deficiency 
anemia  (35). Hepcidin synthesis is induced not only through iron stores but also through 
inflammation, thus acting as a component of innate immunity (8). VDRE is present in the 
promoter region of the hepcidin antimicrobial peptide gene, which provides a strong basis 
for the direct action of vitamin D on hepcidin (8). In subjects with persistent low-grade 
systemic inflammation, hepcidin-induced iron trapping occurs in macrophages. Evidence 
suggests that there exists an anti-inflammatory mechanism of vitamin D on the hepcidin–
ferroportin axis (36). A dose-dependent decrease was observed in the release of IL-6 and 




Vitamin D enhances erythropoiesis by inhibiting proinflammatory cytokines, which may 
impair erythropoiesis by inhibiting the production of erythropoietin and proliferation of 
erythroid progenitor cells (37). It sustains erythropoiesis by increasing burst forming unit-
erythroid proliferation. Moreover, it exerts a synergistic effect with erythropoietin to 
enhance the erythroid progenitor cell (38, 39). 
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Role of vitamin D in neurodevelopment 
 
Vitamin D mediates various functions in the brain (6). The vitamin D activating enzyme 
CYP27B1 and catabolic enzyme CYP24A1 are present in neural cells of the cerebral 
cortex and cerebellar Purkinje cells, suggesting that the brain metabolizes vitamin D (40). 
Vitamin D deficiency in pregnant rat causes extreme alterations in the brains of their 
pups. These alternations include  a longer cortex, proportionately thinner and enlarged 
lateral ventricle at birth, along with reduced nerve growth factor, glial cell line-derived 
neurotrophic factor, and altered p75 neurotrophin receptor (p75NTR) (41, 42). Vitamin D 
deficiency in utero resulted in rat embryos having significantly fewer numbers of 
apoptotic cells and more mitotic cells. Animal models have also revealed that vitamin D 
deficiency during pregnancy is associated with a reduced fetal crown-rump length, head 
size, and lateral ventricle volume (43). Vitamin D deficiency causes alternation of brain-
derived neurotrophic factor, transforming growth factor-β1, and forkhead box protein 
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transcription factor family and play critical roles in regulating the expression of genes 
involved in cell growth, differentiation, and proliferation (43). There was a reduction of 
brain-specific tyrosine hydroxylase gene expression in the substantia nigra following 
vitamin D depletion in mice (43). This change may have significant implication for 
neurodevelopment. 
1,25(OH)2D may affect brain development by downregulating the production of 
cytokines, affecting neurotransmission and synaptic plasticity, which may affect 
neurocognitive development (44). It also affects dopamine activity in the brain, which is 
attributed to the presence of the VDR in brain areas responsive to dopamine (6). 
Vitamin D deficiency may alter the calcium flow through the L-type voltage-dependent 
calcium channels (L-VGCCs) by moderating the transcription of L-VGCCs and protein 
kinases (calcium/calmodulin-dependent protein kinase II, protein kinase A, and 
phosphoinositide 3-kinase). These alterations may contribute to changes in neural nitric 
oxide (NO) synthase (nNOS), which may result in the abnormal secretion of NO into the 
extracellular space. The abnormal NO secretion may increase matrix metalloproteinase-9 
(MMP-9) levels, which may affect both extracellular matrix (ECM) and aggrecan-rich 
perineuronal networks (PNNs), decreasing PNN-positive cells. The decrease in PNN-
positive cells may destabilize the neuronal circuits, resulting in network dysfunctions 
leading to cognitive deficits (Figure 5) (44).  
Despite evidence from animal studies, human studies have reported mixed results on the 
association between vitamin D status and neurodevelopment (45-50). Most of the studies 
have reported an association between pregnancy vitamin D status and 
neurodevelopmental outcomes in children before 4 years, except for a few studies that 
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Evaluation of vitamin D status 
 
Source of vitamin D 
 
Exposure of the skin to sunlight, usually between 10 am and 3 pm in the spring, summer, 
and fall, acts as the most crucial source of vitamin D for humans (52). Several factors 
reduce the skin’s production of vitamin D3, including increased skin pigmentation and 
the topical application of sunscreen (1). A change in the zenith angle of the sun due to a 
change in the latitude, season of the year, or time of the day influences the skin’s 
production of vitamin D3 (1). With latitude of approximately 33-35° above and below 
the Earth's equatorial plane, vitamin D3 synthesis in the skin is very low or absent during 
most of the winter (53, 54).  
Dietary sources of vitamin D are primarily limited to oily fish, eggs, and fortified foods 
(55). 
 
Vitamin D assessment in population-based studies 
 
Measuring serum 25-hydroxyvitamin D (25(OH)D) is the most accurate method for 
assessing the vitamin D status in humans (2, 56). However, serum 25(OH)D 
measurements used in population based research have limitations. Firstly, a single 
assessment of serum 25(OH)D may not accurately reflect an individual’s vitamin D status 
over a year. Serum 25(OH)D levels vary with season; highest concentration are observed 
in the summer and lowest in the winter due to differences in sun exposure (57). For this 
reason, analyses of serum 25(OH)D should be adjusted for the season of blood collection 
to assess the long-term effects of vitamin D. Secondly, there is debate on the cut-offs for 
defining vitamin D deficiency (57). Thirdly, serum 25(OH)D concentration should be 
considered in the context of the genetic variation in proteins involved in the vitamin D 
transport, function, and metabolisms such as VDBP, VDR, 25-hydroxylase (CYP27A1), 
1-alpha-hydroxylase (CYP27B1), and 24-hydroxylase (58). Fourthly, intra-individual 
variation in serum 25(OH)D concentration are not considered while measuring the 
vitamin D status. As a result, serum 25(OH)D measurements at entry into a study may 
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not reflect a person’s long term vitamin D status. Therefore, in the absence of repeated 
longitudinal serum 25(OH)D measurements, the only method available to assess the 
vitamin D status over lifetime is repeated, longitudinal, or retrospective assessments of 
vitamin D intake and sunlight exposure (57). 
 
Definitions of adequate and optimal vitamin D status  
 
The World Health Organization (WHO) and the Nordic Nutrition Recommendations 
(NNR 2012, Nordic Council of Ministers 2014) have defined vitamin D “insufficiency” 
and “deficiency” as a serum 25(OH)D concentration below 20 ng/mL and 10 ng/mL, 
respectively (59). These cut-off values were set with regard to prevention of rickets 
and/or symptomatic osteomalacia. 
According to the US Institute of Medicine’s recommendations, serum 25(OH)D < 12 
ng/mL is “deficient”; serum 25(OH)D of 12-20 ng/mL is “inadequate”; and serum 
25(OH)D > 20 ng/mL is “sufficient”(60). 
The Endocrine Society (www.endocrine.org) suggests that a 25(OH)D concentration of at 
least 30 ng/mL is essential for optimal health outcomes and <20 ng/mL as vitamin D 
deficiency (56, 61). The Endocrine Society considered the following factors to define the 
vitamin D cut off 1) elevated PTH is consistently lowered to a plateau when serum 
25(OH)D is at 30 ng/mL or higher; 2) there is reduction in the risk of falls among older 
persons at serum 25(OH)D levels of 30 ng/mL or higher; and 3) calcium absorption is 
maximal at serum 25(OH)D levels of 30 ng/mL (62). 
Inconsistency in vitamin D cut-off levels used along with interchangeable use of 
terminology, makes accurate comparisons of reported prevalence difficult (59). 
 
Vitamin D deficiency prevalence in low- and middle-income 
countries and India 
 
The prevalence of vitamin D deficiency is reported worldwide, both in sunshine-deficient 
and sunshine-sufficient countries, irrespective of age, sex, and geography. It has been 
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argued that vitamin D deficiency is the most underdiagnosed and undertreated nutritional 
deficiency in the world (63). Table 1 presents the overview of studies on the vitamin D 
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Prevalence of pneumonia, diarrhea, anemia and stunting among 
under five children in India 
 
Globally, pneumonia and diarrhea are two of the primary causes of morbidity and mortality 
among children under 5 years of age. The incidence of clinical pneumonia is 0.37 episodes 
per child per year and India accounts for 36% of the total WHO Southeast Asia regional 
burden (64, 65). In 2000 and 2015, India had 32% of all episodes of clinical pneumonia 
among developing countries, and the incidence of pneumonia decreased by only 3% during 
these 15 years (66). 
Diarrhea attributes to 9% of all under-5 deaths, most of which occur in developing 
countries (67). Although a reduction in the incidence of diarrhea in resource-limited 
settings was observed from 2000 to 2015, the disease burden associated with enteric 
illnesses remains a public health issue. 
Anemia affects a quarter of the global population; nearly 293 million (47%) children under 
5 years of age are anemic (68). Approximately 85% of the anemia burden in children under 
5 years of age is from Asia and Africa (69). According to the recent National Family 
Health Survey-4 (NFHS-4, 2015-2016), 59% of children aged 6–59 months are anemic in 
India, which is alarming and of immense concern (70, 71). 
Global estimates of undernutrition among children under 5 years of age suggest that 150.8 
million children are stunted, 50.5 million children are wasted. India along with Nigeria and 
Pakistan contribute to almost half (47.2%) of all stunted children (72). While stunting and 
underweight prevalence have reduced, trends in wasting indicate an overall increase in the 
past decade in India (73). There was  one percentage point decrease of stunting per year 
from NFHS-3 (2005-2006) to NFHS-4 (2015-2016) (73). Similarly, underweight 
prevalence has been reduced by 0.68 percentage points from NFHS-3 (2005-2006) to 
NFHS-4 (2015-2016) over a decade. Recent data are promising and suggest acceleration in 
the reduction of stunting and underweight. However, the pace of reduction remains low and 
calls for focused interventions for optimal results (73). 
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Neurodevelopment status among children: globally and in India 
 
More than 250 million children under 5 years of age in low- and middle-income countries 
(LMICs) are at a risk of not attaining their complete developmental potential (74). The 
early years of life are critical for the development of cognitive and socio-emotional 
functions (75). Children develop a set of age-appropriate core cognitive skills between 
birth and 5 years that allow them to maintain attention, understand and follow directions, 
communicate with others, and solve progressively complex problems (76). Children with 
developmental deficits lose an estimated 19.8% of adult income yearly (77). 
According to the results from the multiple indicator cluster survey and the demographic 
and health survey, a total of 80.8 million children aged 3-4 years in LMICs had poor 
cognitive or socioemotional development in 2010 (76). Specifically, 14.6% had low early 
childhood development index scores in the cognitive domain, 26.2% had low 
socioemotional scores, and 36.8% performed poorly in either or both areas.  
Recently, a study was conducted in five states of India to assess the population-level 
prevalence of childhood neurodevelopmental disorders (NDDs) among children aged 2-9 
years. The study assessed vision impairment, epilepsy, neuromotor impairments, including 
cerebral palsy, hearing impairment, speech and language disorders, autism spectrum 
disorders, intellectual disability, attention deficit hyperactivity disorder, and learning 
disorders. The total burden of any of the nine NDDs in the 6-9 year old children ranged 
from 6.5% to 18.5% (78). 
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Figure 6 Conceptual Framework for association between vitamin D status and child 
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Rationale for assessing vitamin D status and child health, growth and 
development 
 
Animal studies have suggested that vitamin D plays a critical role in innate and adaptive 
immunity, inflammation, anemia, growth, and neurodevelopment (Figure 6). Primarily, 
vitamin D exerts its nonosteoblastic activities through the VDR, which is widely present in 
different parts of the human body, such as the intestine, bone, kidney, respiratory 
epithelium and the brain. However, few studies have measured the associations between 
the vitamin D status and functions of the respiratory system, hematopoietic cells, bone, and 
brain in a single cohort. In previous cohorts, the time of exposure to vitamin D deficiency, 
use of different cut-offs for vitamin D deficiency, age of the child at the time of outcome 
assessments, and handling of the confounders have varied. These could be the reasons for 
inconsistent findings on the associations between the vitamin D status, and different extra 
skeletal functions in these studies. 
The cohort of young Indian children described in this thesis has provided a unique 
opportunity to measure the associations between vitamin D status in early childhood on 
common childhood infections, such as diarrhea and pneumonia, anemia, physical growth, 
and neurodevelopment at different time points in childhood. The present study consists of a 
cohort of 1000 children included during their early childhood (6-30 months), where we 
were able to follow 791 of them until they were of school going age (6-9 years). Vitamin D 
concentration of 960 children was available during early childhood. Information on 
diarrhea and pneumonia incidence was obtained through biweekly 6 months follow-up, 
hemoglobin (Hb) concentration was measured in early childhood, and physical growth and 
neurodevelopment were measured in early childhood and at school age. Detailed 
information on the exposure of interest (vitamin D concentration) in early life and different 
clinical (infections), biochemical (anemia), physical (growth), and neurodevelopmental 
outcomes at different time points during childhood provides an excellent opportunity to test 
different hypotheses surrounding the extra-skeletal roles of vitamin D. 
 
 
                                                                                                                                                                                   31 




To estimate the association between vitamin D deficiency in early childhood, and  
1. Respiratory infections (ALRIs, clinical pneumonia), and diarrhea in early childhood.  
2. Anemia status in early childhood. 
3. Neurodevelopment and physical growth in early childhood. 
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Methods  
 
The original study on vitamin B12 and/or folic acid supplementation  
 
 
The original study was conducted between January 2010 and February 2012 in low-to-
middle socioeconomic settings in New Delhi, India. The total population of the study site 
was approximately 300,000. One thousand children aged between 6-30 months were 
enrolled in this randomized, double-blind placebo-controlled factorial trial (NCT00717730 
at www.clinicaltrials.gov) to evaluate the impact of supplementation with folic acid, 
vitamin B-12, or both on childhood infections. The children were randomized to one of 
four treatment groups: 1) placebo (n = 249), 2) 2 times the Recommended Dietary 
Allowance (RDA) of folic acid (n = 249), 3) 2 times the RDA of vitamin B-12 (n = 252), 
and 4) a combination of both vitamin B-12 and folic acid (n = 250) (79). 
 
Inclusion and exclusion Criteria 
 
Caregivers of children aged 6-30 months who consented to participate and with no plans to 
move away over the next 6 months of supplementation were considered for enrollment. We 
excluded children with severe systemic illness requiring hospitalization, severe acute 
malnutrition (weight-for-height Z score <-3 SD), severe anemia (Hb <7 g/dL), and those 




The intervention was a lipid-based nutritional supplement prepared by NUTRISET Ltd. 
Children aged 6-11 months received one spoon (5 g), and children older than 12 months 
received two spoons (10 g). The supplement was administered daily by a fieldworker for 
six months at the participants’ homes, except on Sundays and public holidays when the 
mother administered the supplement herself. Each 10 g (corresponding to the daily dose for 
children older than 12 m) contained 54.1 kcal energy, 0.7 g protein, and 3.3 g fat. The 
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supplement contained 150 mcg folic acid for the folic acid groups and 1.8 mcg vitamin B-
12 for the vitamin B-12 groups (79). 
 
Blood sample collection and processing 
 
We obtained 3 mL blood samples from all children at enrollment in a tube containing 
EDTA (Becton Dickinson). The plasma was centrifuged at approximately 450 × g at room 
temperature for 10 min, separated, and transferred into storage vials and stored at -20 
0
 C 
until analyzed (79). 
 
Assessment of vitamin D  
 
We used the quantitative electrochemiluminescence-binding assay to measure the plasma 
concentration of vitamin D (Roche Diagnostics, Mannheim, Germany) (80). 
 
Hemoglobin, vitamin B-12, folate, and homocysteine assessment  
 
HemoCue AB (HemoCue Hb Angelholm, Sweden) was used to measure Hb concentration 
(81, 82). Microbiological assays estimated plasma concentration of vitamin B-12 and folate 
(83, 84). Plasma soluble transferrin receptor (sTfR) was analyzed using an 
immunoturbidimetric assay (85). Total plasma homocysteine (tHcy) was analyzed using 
kits (Abbott Laboratories, Abbott Park, IL, USA) (86). 
 
Assessment of infection  
 
Field workers visited households twice weekly for six months post enrollment. During 
these visits, they asked the mothers or primary caregivers about symptoms of respiratory 
illness (cough, difficult breathing, fast breathing), diarrheal disease (number and 
consistency of stools), fever on any day since the last visit, and care-seeking behaviors for 
the illnesses. The workers counted respiratory rates twice at each visit, measured 
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temperature, and examined for signs of dehydration if the child had diarrhea or 
vomiting (87). 
 
Neurodevelopment assessments in the original study 
 
Neurodevelopment was assessed after six months of supplementation using the Ages and 
Stages Questionnaire 3
rd
 edition (ASQ-3). The ASQ-3 consists of age-appropriate 
questionnaires divided into five subscales: Communication, Gross motor, Fine motor, 
Problem-solving, and Personal-social. The items are summed to reveal subscale scores 
ranging from 0 to 60, and these subscale scores are further summed to obtain a total score 
ranging from 0 to 300 (88). 
The ASQ-3 forms were translated to Hindi, the spoken language in the study area (89). The 
field supervisors performed the forward translations. The translations were then back-
translated to English by another person who was otherwise not involved in the study (89). 
Four items in the ASQ-3 were identified not to be appropriate for the study population and 
were changed; these were an item involving a fork, an item involving a zipper, an item 
involving a mirror, and one requiring the child’s knowledge of his/her first and last name 
(89). 
We asked questions to assess the stimulation and learning environment of the children. 
Questions included number of toys in the home, number of hours of play during the week 
and numbers of books. We also used two questions from the Home Observation for the 
Measurement of the Environment (HOME) to assess the caregiver’s encouragement of 
developmental advances and her/his promotion of child development (90). 
 
The follow up study on vitamin B12 and/or folic acid supplementation  
 
In September 2016, approximately six years after the end of the original study, the team 
contacted the 1000 children enrolled in the original study, of whom 798 (79.8%) children 
were available. Of these, 791 consented for participation in the follow up study (91). The 
children were then 6-9 years old.  
 
                                                                                                                                                                                   35 
   
 
Neurodevelopment assessments in the follow-up study  
 
In the follow-up we performed a comprehensive assessment of cognitive functioning (91). 
The Wechsler Intelligence Scale for Children 4th edition (India) (WISC-IV
INDIA
) is an 
assessment tool for intellectual ability in children that has been validated for the Indian 
population and has Indian norms (92). For the current study, we used seven subtests, which 
were summed to obtain three index scores; perceptual reasoning, processing speed, and 
working memory. 
The Crichton Vocabulary Scale (CVS) is a tool for the assessment of language skills for 
children 4 to 18 years old (93). The CVS has been translated to Hindi and provides a 
standard total score according to Indian norms (94).  
The NEPSY-II is a neuropsychological test battery for children aged 3 to 16 years with 
American norms (95). We administered seven age-appropriate subtests: inhibition, design 
fluency, word generation, visuomotor precision, manual motor sequences, affect 
recognition, and geometric puzzles. No modifications or cultural adjustments were 
necessary to perform the tests in this setting.  
The Behavior Rating Inventory of Executive Function 2nd edition (BRIEF 2) is a parent-
reported questionnaire for children 5 to 18 years of age assessing executive functions in 
everyday life according to American norms (96). The scale comprises of three clinical 
indexes; the behavior, emotion and regulation index; and an overall global executive 
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Anthropometry 
 
Weight (Digitron scales, to the nearest 50 g), length (locally manufactured infantometers, 
to the nearest 0.1 cm), and height (Seca 213, to the nearest 0.1 cm) were measured at 6-30 
months age in the original study, and at 6-9 years in the follow up study.  
 




Vitamin D deficiency was defined as vitamin D concentration <10 ng/mL (59). We also 
categorized vitamin D status according to the US Institute of Medicine`s recommendations; 
serum 25(OH)D <12 ng/mL as ‘deficient’; 12-20 ng/mL as ‘inadequate’; and >20 ng/mL as 
‘sufficient’. We also used vitamin D concentration as continuous variable in generalized 




We defined diarrhea as the passage of 3 or more loose or watery stools in a 24 hours 
period. Two different episodes of diarrhea were separated by ≥3 days (72 h) without 
diarrhea. 
We defined ALRIs as cough or difficult breathing with an increased respiratory rate above 
the age-specific cutoff values (≥ 50 breaths/min and ≥ 40 breaths/min in infants and older 
children, respectively) or cough or difficult breathing and lower chest indrawing (87). 
We defined clinical pneumonia either by a combination of cough with crepitations or 
bronchial breathing by auscultation or as an episode of ALRIs associated with at least one 
of the following features: lower chest indrawing, convulsions, inability to drink or feed, 
extreme lethargy, restlessness or irritability, nasal flaring, or abnormal sleep and difficulty 
in waking (87). 
We defined anemia as Hb concentration <11 gm/ dL, mild anemia as Hb concentration 10 
to 10.9 gm/ dL, moderate anemia as Hb concentration 7 to 9.9 gm/ dL, and severe anemia 
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as Hb concentration <7 gm/dL based on WHO criteria (97). Iron deficiency was defined as 
soluble transferrin receptor (sTfR) concentration >4.7 nmol/L (98). We defined vitamin B-
12 deficiency as plasma vitamin B-12 concentration of <200 pmol/L, folate deficiency as 
plasma folate concentration of <7.5 nmol/L, and high tHcy level as total homocysteine 
concentration ≥ 10 µmol/L. (99, 100) 
Wasting was defined as weight-for-height/length Z scores (WHZ/WLZ) < −2SD, stunting 
as height/ length-for-age Z scores (HAZ/LAZ) <−2SD, and underweight as weight-for-age 
Z scores (WAZ) < −2SD according to WHO standards (101). 
 




To estimate the association between vitamin D deficiency and ALRIs, clinical pneumonia 
and diarrhea, 960 children were available. With this number we had more than 90% power 
to detect a relative risk of 1.3 between vitamin D deficiency and ALRIs, assuming a 40% 
prevalence of at least one episode of ALRIs in the vitamin D non-deficient group at a 5% 
significance level. With this number we had at least 80% power to detect a relative risk of 
1.3 between vitamin D deficiency and clinical pneumonia, assuming a 30% prevalence of 
at least one episode of clinical pneumonia in the vitamin D non-deficient group at a 5% 
significance level. With this number we had more than 80% power to detect a relative risk 
of 1.3 between vitamin D deficiency and diarrhea, assuming a 35% prevalence of at least 
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To estimate the association between vitamin D deficiency and anemia, 960 children were 
available. With this number we had more than 90% power to detect a relative risk of 1.3 
between vitamin D deficiency and moderate anemia, assuming a 40% prevalence of 
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To estimate the association between vitamin D deficiency and neurodevelopment and growth 
in early childhood, 401 and 960 children were available, respectively. With these numbers 
we had more than 80% power to detect at least a 0.3 SD difference in the total ASQ-3 
scores between the vitamin D deficient children and vitamin D non-deficient children at a 
5% significance level. We also had more than 80% power to detect at least a 0.2 SD 
difference in the mean LAZ scores between vitamin D deficient children and vitamin D 
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To estimate the association between vitamin D deficiency and neurodevelopment and growth 
at school age, 716 children were available. With this number we had more than 90% power 
to detect a 0.3 SD difference in WISC-IV
INDIA
 and CVS Z scores between the vitamin D 
deficient children and the vitamin D non-deficient children at a 5% significance level. We 
also had more than 80% power to detect at least a 0.21 SD difference in mean LAZ scores 





                                                                                                                                                                                   41 
   







We summarized baseline characteristics with measures of dispersion such as the mean with 
standard deviation, median with interquartile range, and the percentage by vitamin D status 
at baseline, as appropriate. We used a method of purposeful selection of covariates to 
identify variables to be included in the multivariable models (102). Generalized additive 
models (GAM) were used to explore nonlinear associations between vitamin D 
concentration at baseline and different outcomes, such as the incidence of ALRIs, Hb 
concentration, LAZ/HAZ scores, and different neurodevelopmental scores (103).  
We created a wealth index that determined the wealth of an individual using principal 
component analysis based on assets owned by the household (104). The study population 
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was categorized into five equal wealth quintiles, i.e., ‘poorest’, ‘very poor’, ‘poor’, ‘less 
poor’, and ‘least poor’, based on principal component analysis.  
We used STATA version 15 (Stata Corporation, College Station, TX) and R version 3.1.2 




To estimate the association between vitamin D deficiency and ALRIs, clinical pneumonia 
and diarrhea, we used generalized estimating equations (GEEs) with a logit link, binomial 
variance first-order autoregressive (AR1) covariance-variance matrix and robust standard 
error, taking time into account. We divided the six month follow up period of each child 
into 26 periods of 7 days. For a period to be included in the analyses, we required 
information on 4 or more days of the given 7 days’ period. We adjusted for the age, sex, 
breastfeeding status, wasting, stunting, underweight, anemia status of the children, season, 
and intervention groups. The GAM was used to explore nonlinear associations between 




To estimate the association between vitamin D deficiency and anemia, we used a 
multivariable logistic regression model.  We adjusted for family income, age of the child, 
mothers’ years of schooling, stunting, season, baseline plasma folate, plasma soluble 
transferrin receptor saturation, and plasma homocysteine level. 
We used multinomial logistic regression analysis to measure the association between 
vitamin D deficiency and different categories of anemia (mild, moderate) compared to no 
anemia at baseline.  
We performed a dominance analysis to show the relative importance of different 
erythropoietic nutrients (folate, vitamin B-12, sTfR) on Hb status.  
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Objective 3 
 
To estimate the association between vitamin D deficiency and neurodevelopment we used 
multivariable linear and logistic regression models. In linear regression models, we used 
the ASQ-3 scores as continuous variables. In logistic regression models, we categorized the 
total and subscale ASQ-3 scores at the 25th percentile. We adjusted for the child’s age, 
mother’s years of schooling, father’s years of schooling, log-transformed annual family 
income, family structure, hours of play with other children during the week, family owns 
books, number of children in the family, mother’s encouragement of developmental 
advances, mother’s belief that child’s behavior can be modified, WLZ/WHZ, WAZ and 
intervention group.  
To estimate the association between vitamin D deficiency and growth, we used 
multivariable linear and logistic regression models. We used wasting, stunting, and 
underweight as dependent variables in the logistic regression models and WHZ/WLZ, 
LAZ/HAZ, and WAZ in the linear regression models. In these models, we adjusted for 
family structure, age of the child, sex of the child, breastfeeding status, log-transformed 
annual family income, mother’s and father’s years of schooling, baseline levels of vitamin 




To estimate the association between vitamin D deficiency and neurodevelopment and growth 
at school age, we used generalized linear model (GLM). In these models, we used the 
Gaussian distribution family and identity link function to estimate beta coefficients for the 
cognitive outcomes and HAZ (28). We used the poisson distribution family and log link to 
calculate the relative risk (RR) for stunting (105). 
We calculated a combined WISC-IV 
INDIA
 and CVS Z-scores based on converted Z-scores 
for the three index scores in the WISC-IV INDIA (perceptual reasoning, processing speed, 
and working memory) and the total CVS scores. We also calculated a combined NEPSY-II 
Z score based on the converted Z-scores in the seven subtests (IN-naming vs. inhibition 
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contrast scaled scores, design fluency total scaled scores, word generation-semantic vs. 
initial letter contrast scaled scores, visuomotor precision combined scaled scores, manual 
motor sequences total scores - raw scores, affect recognition total scaled scores, and 
geometric puzzles total scaled scores). For BRIEF 2, we used the overall global executive 
composite scores in the analyses.  
In these models, we adjusted for log folate level, log soluble transferrin receptor level and 
log total homocysteine level at baseline and the wealth index, father’s occupational status, 
maternal education at follow-up and intervention groups.  
Ethics 
 
The ethics committees of the Society for Applied Studies, New Delhi, and the Norwegian 
Regional Committee for Medical and Health Research Ethics (REK VEST) approved all 
procedures in the original and follow up studies. The consent form for the original study 
also sought permission from parents to store their children’s blood samples for use in 
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Results 
 
Blood samples for vitamin D estimation were available for 960 (96%) children at baseline. 
Of these, 331 (34.5%) children had vitamin D concentration <10 ng/mL and were classified 
as vitamin D deficient. The baseline characteristics of the enrolled children and their 
families by vitamin D deficiency status are shown in Table 2. More than a third (36.4%) of 
the children were stunted, 31% were underweight, and 10.7% were wasted. Approximately 
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Table 2 Baseline characteristics of vitamin D deficient and non-deficient children 
aged 6-30 months included in the analysis  
 Deficient Non-deficient 
Baseline characteristics n = 331 n = 629 
Infant characteristics    
Age at enrolment in months, mean (SD) 16.9 (7.1) 15.8 (7.0) 
Children    
         <12 months 91 (27.5%) 210 (33.4) 
         12 to 23 months 166 (50.1) 306 (48.7) 
         24 to 30 months 74 (22.4) 113 (18.0) 
Boys 162 (48.9) 328 (52.2) 
Ever breastfed 325 (98.2) 622 (98.9) 
Illness in previous 24 hours   
Diarrhea 17 (5.1) 32 (5.1) 
Cough or difficult breathing or fast 
breathing                        114 (34.4) 192 (30.5) 
Nutritional status   
WHZ/WLZ, mean (SD) -0.86 (0.92) -0.89 (0.94) 
HAZ/LAZ, mean (SD) -1.56 (1.24) -1.63 (1.16) 
WAZ, mean (SD) -1.46 (1.06) -1.52 (1.05) 
Wasted  35 (10.6) 68 (10.8) 
Stunted  117 (35.3) 233 (37.0) 
Underweight  101 (30.5) 197 (31.3) 
Anemia (Hb<11 g/dL) 244 (73.7) 424 (67.4) 
Socio-demographic characteristics   
Mother’s age in years, mean (SD) 26.3(5.8) 25.6(4.1)  
Mother’s schooling in years, median (IQR)  8 (5,10) 7 (0,10)  
Father’s schooling in years, median (IQR)  10 (7,12) 9 (6,12) 
Annual family income in rupees, median 
(IQR)  
72000  
(60000 - 144000) 
84000  
(60000 - 138000) 
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Figure 10 depicts how the vitamin D concentration varies throughout the year. The baseline 
vitamin D concentration was higher in children who were enrolled from May to July 
(weeks 24 to 32) and lower in the period from December through February (weeks 48 to 8).   
 
 





The solid line depicts the association of vitamin-D concentration at baseline and weeks of 
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Synopsis of Paper 1 
Specific Objective 
To estimate whether vitamin D deficiency (<10 ng/ mL) at 6-30 months of age determines 
ALRIs, clinical pneumonia, and diarrhea incidence during a six-month follow-up period.   
Results 
The risk of ALRIs was significantly higher among vitamin D deficient children than among 
non-deficient children (OR: 1.26; 95% CI: 1.03 to 1.55), while clinical pneumonia was not 
associated (OR: 1.05; 95% CI: 0.79 to 1.38) with vitamin D status (Table 3). 
We found no association between vitamin D status and episodes of diarrhea overall or 
episodes lasting for six days or more.  
 
Table 3 Incidence of ALRIs and clinical pneumonia in vitamin D deficient and non-
deficient children 





(Vitamin D level 
< 10 ng/mL) 
(n=331) 
(Vitamin D level ≥ 
10 ng/mL)
a   
(n=629) 




Episodes of ALRIs  244 418 
Incidence density of ALRI 
per child year (95% CI) 
1.50  
(1.32 to 1.70) 
1.35  
(1.23 to 1.49) 
1.26  
(1.03 to 1.55) 
 








Incidence density of clinical 




(0.75 to 1.04) 
 
0.95  
(0.85 to 1.07) 
 
1.05  
(0.79 to 1.38) 
a 
Reference category: Non-deficient (vitamin D concentration ≥ 10 ng/mL) 
b
 ORs were calculated by using generalized estimating equations with a logit link, binomial variance, 
autoregressive correlation, and robust standard error and adjusted for age, sex, breastfeeding status, wasted, 
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The relationship between vitamin D concentration and incidence of ALRIs appeared to be 
almost linear, as indicated by the GAM plot (Figure 11). In the GAM, we removed the 
highest 1.5% (vitamin D concentration >40 ng/mL) from the analyses as the estimated 
GAM curve beyond this cut-off was highly uncertain. 
 





The solid line depicts the association of vitamin D concentration at baseline and ALRI 
incidence density. The shaded area spans the 95% confidence interval of this association. 
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Synopsis of Paper 2 
Objective 
To examine the association between vitamin D deficiency and anemia status among 
children 6-30 months of age  
Results 
The prevalence of anemia among vitamin D deficient and non-deficient children is shown 
in Table 4. We did not find any association between vitamin D deficiency and overall 
anemia after adjusting for confounders. However, anemia was categorized into mild and 
moderate, we found an association between vitamin D deficiency and moderate anemia 
(OR: 1.58; 95% CI: 1.09 to 2.31).  
 
Table 4 Prevalence of anemia in vitamin D deficient and non-deficient children 
a 
Reference category: Non-deficient (vitamin D concentration ≥ 10 ng/mL) 
b 
ORs were calculated by using logistic regression, and adjusted for age, family income, mothers years of 
schooling, stunted, season, baseline plasma folate, plasma soluble transferrin receptor saturation, plasma 
homocysteine 
c 
ORs were calculated by using multinomial logistic regression, and adjusted for age, family income, 
mothers years of schooling, stunted, season, baseline plasma folate, plasma soluble transferrin receptor 






(vitamin D level  
< 10 ng/mL) 
(n=331) 
Non-deficient 














(Hb <11 gm/dL) 
244 (73.7) 424 (67.4) 
 
1.35  
(1.01 to 1.82) 
 
1.35  
(0.96 to 1.88) 
    Moderate Anemia 
    (Hb 7 to 9.9      
gm/dL) 
 
173 (52.3) 267 (42.4) 
1.53  
(1.11 to 2.09) 
   
1.58  
(1.09 to 2.31) 
 
    Mild Anemia 
   (Hb 10 to 10.9 
gm/dL) 
71 (21.5) 157 (25.0) 
1.06  
(0.73 to 1.55) 
 
1.14  
(0.77 to 1.69) 
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The GAM plot revealed that here was no association between vitamin D and 
haemoglobin levels at baseline (Figure 12). We removed the highest 1.5% (vitamin D 
>40 ng/mL) from the analyses as the estimated GAM curve beyond this cut-off was 
highly uncertain.  
 
Figure 12 Association between baseline vitamin D and hemoglobin concentration  
 
  
The solid line depicts the association of vitamin D and hemoglobin concentration at 
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Synopsis of Paper 3 
 
Objective 
To estimate whether vitamin D deficiency (<10 ng/ mL) is associated with 
neurodevelopment and physical growth in young children 
Results 
The overall ASQ-3 scores were not significantly different between the vitamin D-
deficient children and the vitamin D non-deficient children (mean difference -6.54; 95% 
CI: -16.15 to 3.08). The Personal-social subscale score was significantly lower in the 
vitamin D deficient children (mean difference -2.63; 95% CI: -5.00 to -0.25), while the 
other subscale scores were not different between the groups. We also categorized the total 
ASQ-3 scores into two categories: scores <25
th
 percentile and scores ≥25
th
 percentile. 
After adjusting for potential confounders, we found a greater odds of having scores in the 
lowest 25
th
 percentile of the Personal-social score in the vitamin D deficient children 
compared to the non-deficient children (OR: 1.63; 95% CI: 1.03 to 2.58). We did not 
detect such differences for the other subscale scores or for the overall total ASQ-3 score 














                                                                                                                                                                                   53 
   
 
Table 5 Association between baseline vitamin D status and ASQ-3 scores  
 Non-deficient 
(Vitamin D level≥10 
ng/mL) 
Deficient 
(Vitamin D level < 10 
ng/mL) 
 
 OR Adjusted OR 
a,b,c 
95% CI 
Total ASQ-3 1 1.36 0.79 to 2.31 
Subscale 
Communication 1 1.58 0.97 to 2.59 
Gross motor 1 1.27 0.80 to 2.03 
Fine motor 1 1.31 0.81 to 2.11 
Problem-
solving 
1 1.33 0.84 to 2.11 
Personal-Social 1 1.63 1.03 to 2.58 
a 




for the lower quartile of total ASQ-3 and subscale scores compared with non-deficient vitamin D 




 Adjusted for age of child, mother’s years of schooling, father’s years of schooling, log-transformed 
annual family income, family structure, number of toys available, family owns books, number of children 
in the family, hours of play with other children during the week, mother’s belief that a child`s behaviour 
can be modified, mother’s encouragement of developmental advances, WLZ/WHZ scores, WAZ scores, 
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We were not able to identify any non-linear associations between the vitamin D 
concentration and the ASQ-3 scores (Figure 13). In the GAM, we removed the highest 
1.5% (vitamin D concentration >40 ng/mL) from the analyses as the estimated GAM 
curve beyond this cut-off was highly uncertain.  
 





The solid line depicts the association of vitamin-D concentration at baseline and total 
ASQ-3 score. The shaded area spans the 95% confidence interval of this association 
 
Vitamin D deficiency was not associated with stunting, wasting, or underweight in this 
population. 
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Synopsis of Paper 4 
Objective 
To examine whether vitamin D deficiency in early childhood is associated with cognitive 
development and linear growth measured during school age. 
Results 
The demographic characteristics of the children and their families in the follow up study 
are presented in Table 6. The mean (SD) age of the children was 7.9 (0.6) years. 
Approximately 98% of children were going to school at the time of the assessments. 
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Table 6 Baseline characteristics of vitamin D deficient and non-deficient children at 












Child characteristics  
  
 







      None  3 (1.9) 6 (2.6) 4 (1.2) 
      Hindi medium 61 (39.6) 88 (37.6) 129 (39.3) 
      English medium 90 (58.4) 140 (59.8) 195 (59.4) 
Family characteristics  
  
 
Mothers years of schooling 
  
 
     Never been to school 54 (35.5) 65 (28) 76 (23.3) 
     Primary (1- 5 years) 23 (15.1) 18 (7.8) 49 (15) 
     Middle (6-12 years) 65 (42.8) 123 (53) 153 (46.9) 





     Government job or private services 88 (57.1) 135 (57.9) 165 (50.8) 
     Self-employed 31 (20.1) 56 (24) 95 (29.2) 
     Daily wager/farming 29 (18.8) 31 (13.3) 52 (16) 








Wealth Quintile    
     Poorest 39 (25.3) 47 (20.1) 60 (18.3) 
     Very Poor 36 (23.4) 38 (16.2) 65 (19.8) 
     Poor 31 (20.1) 57 (24.4) 60 (18.3) 
     Less Poor 32 (20.8) 43 (18.4) 69 (21) 
     Least Poor 16 (10.4) 49 (20.9) 74 (22.6) 
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The association between vitamin D deficiency and the WISC-IV
INDIA
 and CVS z-scores, 
NEPSY-II z-scores and the Global BRIEF-2 scores are shown in Table 7. There were no 
significant differences between the vitamin D sufficient children and those with 
inadequate or deficient vitamin D status on any of the cognitive outcomes. Furthermore, 
vitamin D status was not associated with HAZ scores or the proportion of children 
stunted at follow up. 
 
  




 and CVS 
z-score NEPSY z-score 
 



































































(-2.53 to 1.77) 
a
adjusted for log folate, log soluble transferrin receptor and log homocysteine levels at 
baseline, and the wealth index, paternal occupational status, and maternal education at 
follow-up and intervention groups.  
 
The GAM models did not reveal any non-linear associations between the vitamin D 
levels at baseline and the combined WISC-IV
INDIA
 and CVS z-score, the NEPSY-II z-
score or the Global BRIEF-2 score at follow-up (Figure 14). We removed the highest 5% 
(vitamin D concentration >30 ng/mL) from the analyses as the estimated GAM curve 
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Figure 14 Association between baseline vitamin D concentration and the combined 
WISC-IV
INDIA
 and Crichton Vocabulary Scale (CVS) z-score, the combined NEPSY 
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The solid line depicts the association of vitamin D concentration at baseline and WISC-
IV
INDIA
 and Crichton Vocabulary Scale (CVS) z-score, the combined NEPSY II z score, 
and the BRIEF P Global Executive composite score at follow up. The shaded area spans 
the 95% confidence interval of these associations.  
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Discussion 
 
Our key findings are that approximately 35% of the children had vitamin D deficiency 
(<10 ng/mL) in early childhood, and this was associated with a higher risk of ALRIs and 
moderate anemia (Hb 7 to 9.9 g/dL). Vitamin D deficiency was not associated with 
neurodevelopment and growth during early childhood (6-30 months) or at school age (6 
to 9 years). 
 
Vitamin D deficiency 
 
The high prevalence of vitamin D deficiency during early childhood is similar to the 
results from other studies in India and south east Asia (106-109). This can have two 
primary causes; inadequate sun exposure or low dietary intake of vitamin D. Inadequate 
sun exposure may be due to the relatively high solar zenith angle, atmospheric pollution, 
the type V skin of the population, and restricted outdoor activities (110, 111).  If there is a 
higher solar zenith angle, more UVB photons are absorbed in the stratospheric ozone 
layer. Consequently, fewer UVB photons can penetrate the earth’s surface to produce 
cutaneous pre-vitamins (110). Air pollution can cause vitamin D deficiency in two ways; 
directly by blocking UVB photons and indirectly by restricting outdoor activities, thus 
allowing less exposure to sunlight (112).  Individuals with type V skin have significant 
constitutive pigmentation (melanin), which protects the underlying skin against damage 
from UVR and thus reduces vitamin D synthesis (113). We conducted the current study 
in an urban slum where houses are clustered with small open spaces. Additionally, the 
lack of space offers limited options for outdoor activities. Dietary sources of vitamin D 
are primarily limited to oily fish, eggs, and fortified foods (55). As most of the population 
in northern India is vegetarians, the predominant dietary source of vitamin D among the 
study children would be milk (114) . In India, milk is rarely fortified with vitamin D and 
the vitamin D content of unfortified milk is very low (2 IU/100 mL) (63). The prevalence 
of lactose intolerance also contributes to vitamin D deficiency in this setting (63). The 
complementary foods given to Indian children are primarily cereal based and these are 
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low in vitamin D content. This is another contributing factor of the widespread vitamin D 
deficiency among children in this setting (115). 
 
Vitamin D and common childhood infections 
 
We found a higher incidence of ALRIs among vitamin D deficient children than among 
those that were non deficient. We did not find any association between clinical 
pneumonia, a severe form of ALRIs, and vitamin D status. 
Similar to our findings, a systematic review of observational studies has shown that 
vitamin D deficiency was more prevalent (OR: 3.29, 95% CI: 1.27–8.56) in children with 
lower respiratory tract infections (LRTIs) than in those without lower respiratory tract 
infections (116). Moreover, mean vitamin D concentration in children with LRTIs were 
significantly lower than those in children with no LRTIs, with a mean difference of 8.75 
(95% CI:1.80 to 15.70 ) nmol/L (116). The Cochrane review on vitamin D 
supplementation for preventing infections in children under five years of age, showed 
that vitamin D supplementation did not reduce  episodes of ‘radiologically confirmed’ 
first or only episode of pneumonia (RR: 1.06; 95% CI: 0.89 to 1.26; two trials, 3134 
participants) (117). 
The protective role of vitamin D against ALRIs may be through its modulatory effect on 
innate and adaptive immunity and the inflammatory cascade (7, 118-120). Vitamin D 
induces TLR activation and antibacterial responses, which in turn enhance the production 
of cathelicidin (LL-37), an antimicrobial peptide that is present at different natural barrier 
sites, such as the lungs (121). Vitamin D has effects on both innate and adaptive immune 
responses, which may suggest a  different role  according to pathogens and severity 
(122). Vitamin D might not have a role once an infection sets in, other individual and 
environmental factors may determine its natural course. This could be the reason we 
found a significant association between vitamin D deficiency and ALRIs but not with 
clinical pneumonia. 
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Vitamin D deficiency was not associated with the incidence of diarrhea or its severity in 
our study, which is similar to findings from other observational studies (123). A 
randomized controlled trial (RCT) of 3-monthly bolus vitamin D3 supplementation 
(100,000 IU) among children 1 to 29 months of age, showed no effect on diarrheal 
illnesses (124). Constant exposure to pathogenic organisms and subsequent clinical and 
subclinical enteric infections are frequent in these children and could reduce the potential 
beneficial role of vitamin D on diarrheal illnesses in the study setting (125). 
 
Vitamin D and anemia 
 
We found an increased risk of moderate anemia among children with vitamin D 
deficiency. This finding is consistent with an increased risk of anemia among vitamin D 
deficient children and adolescents both in developed and developing countries (126). 
Several mechanisms could explain our findings. Vitamin D enhances erythropoiesis by 
inhibiting pro-inflammatory cytokines, which may impair erythropoiesis by inhibiting the 
production of erythropoietin and proliferation of erythroid progenitor cells (8). Vitamin D 
also causes direct suppression of hepcidin mRNA transcription which leads to less 
production of hepcidin. This process leads to the availability of more iron for intestinal 
absorption (8).  
 
Vitamin D and neurodevelopment 
 
Our study did not show a significant association between vitamin D deficiency and 
neurodevelopment during early childhood measured by the ASQ-3 except for in the 
Personal-social sub scale. The association was not strong and could very well be a chance 
finding. There were no significant differences in any of the cognitive outcomes; the 
combined WISC-IV
INDIA
 and CVS z-score, the combined NEPSY-II z-score and the 
Global BRIEF-2 composite score between categories of vitamin D status in school age 
children.  
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Our findings are similar to those from a recent cohort study in India, where vitamin D 
status was not associated with gross motor functioning among children aged 5 years 
(127). In contrast, another study in a similar setting suggested an inverted-U–shaped 
relationship between neonatal vitamin D status and neurocognitive development in 
children aged 16-18 months (128). Children in the lowest quintile of cord blood 25(OH)D 
concentration exhibited a deficit of 7.60 (95% CI: 2.82 to 12.4) and 8.04 (95% CI: 3.11 to 
12.9) points in the Mental development index (MDI) and psychomotor development 
index (PDI) scores of Bayley Scales of Infant Development second edition, respectively, 
compared with the reference category. In this study, children in the highest quintile of 
cord blood 25(OH)D concentration, also showed a significant deficit of 12.3 (95% CI: 
6.67 to 17.9) points in PDI scores compared with the reference category. However, 
higher levels of vitamin D (≥ 20 ng/mL) showed a positive association with reported 
temperament (activity and soothability), reported receptive language and directly 
observed behavior but not with cognitive and motor development among infants aged 6-8 
months in Bangladesh (129). Studies that have examined the association between cord 
blood vitamin D concentration or vitamin D deficiency during pregnancy with 
neurodevelopment measured in early childhood and school age, have shown inconsistent 
results (91, 128, 130-137). These are likely due to differences in the populations, the 
timing of vitamin D assessment during pregnancy, the use of different cut-offs for 
vitamin D deficiency, age of the child at the neurodevelopmental assessments, and the 
way potential confounders were adjusted for.   
Available evidence from cellular mechanisms of vitamin D suggests that vitamin D may 
play an essential role in neurodevelopment. Vitamin D may have an effect on brain 
development through its anti-inflammatory, anti-autoimmune effects, increasing Treg 
cells, enhancing DNA repair mechanisms, upregulating glutathione and protecting 
mitochondria (138). However, our findings suggest that these mechanisms may not be 
relevant for the impact of vitamin D on cognition neither during early childhood nor at 
school age. Multiple factors interplay for impaired neurodevelopment during childhood 
in low resource settings, such as inadequate early stimulation, inflammation, infection, 
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and micronutrient deficiencies (75). The influence of vitamin D may be of limited 
importance when viewed with other important factors that influence neurodevelopment in 
these children. 
 
Vitamin D and linear growth 
 
Vitamin D deficiency was not associated with linear growth during early childhood or at 
school age. Similar findings were seen in infants in Bangladesh, preschool children in 
Nepal and HIV-exposed but uninfected infants in Africa (129, 139, 140). In a study in 
Indian low-birth-weight (1.8 to 2.5 kg) infants however, vitamin D supplementation of 1 
RDA  resulted in significantly higher length and weight at six months of age compared to 
those who received placebo (141).  
Linear growth during early childhood and school age is regulated by different endocrinal 
factors. While the early childhood phase is primarily regulated by insulin-like growth 
factor-1 (IGF-1), insulin-like growth factor-2 (IGF-2) and insulin, the school age period 
is primarily dependent on growth hormone (GH) and thyroxin (142). Recent studies have 
shown that vitamin D, GH and IGF-1 may have an impact on epiphyseal chondrocytes. In 
addition vitamin D helps the growth plate cells to be more sensitive to GH and IGF-1 
action (143). Vitamin D also maintains bone health ensuring normal calcium and 
phosphate levels in the blood. 1,25 (OH)2D) along with PTH and calcitonin acts to 
maintain endocrine control of calcium and phosphorus concentration in blood (11). This 
tight regulation of calcium and phosphorus flux (extracellular [bones, blood], 
intracellular) is critical for the development and maintenance of bones, which prevents 
growth faltering (144). Our findings of no association between vitamin D deficiency and 
linear growth may hence be unexpected. There may be deficiencies of other growth-
limiting macro and micronutrients, such as calcium, zinc, and vitamin B12 that may 
account for the variance of growth in these children. Poor quality of food, i.e., a lower 
proportion of animal-sourced protein, may also contribute to impaired growth in children 
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in this population (145). The role of vitamin D may accordingly be negligible in the light 




The accuracy of the results from an epidemiological study depends on the validity and 
precision of the measurements and effect estimates. The validity of a study can be 
categorized into internal validity and external validity. Most violations of internal validity 
can be classified into three groups, selection bias, measurement bias, and confounding. 
The precision of the effect estimates depends on the sample size, variability, and random 




Selection bias occurs when the study population is systematically different from those 
who are not included in the study. Specific definitions for inclusion and exclusion criteria 
and low attrition rates may reduce the chance of selection bias (146). In the original 
study, children with severe systemic illness requiring hospitalization, severe acute 
malnutrition (WLZ/WHZ <-3 SD), severe anemia (Hb <7 g/dL), and those who were 
using folic acid and/or vitamin B-12 supplements were excluded. The attrition rate was 
<1% during the six months follow up period (79). We were able to include ~80% 
(791/1000) of the children from the original cohort after more than 5 years of study 
completion. The prevalence of vitamin D deficiency may be different in those who were 
excluded and lost to follow-up. There were, however, no differences between the children 
who were included in the analyses and those who were not. We therefore believe that 




Measurement errors can be of two types; systematic and random. Random measurement 
error occurs when measurements fluctuate unpredictably around their true values and is 
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caused by imprecise measurement tools, true biological variability, or both (147). For 
example, a single assessment of serum 25(OH)D may not accurately reflect an 
individual’s vitamin D status over a year. The serum 25(OH)D levels vary with season; 
highest concentrations are observed in the summer and lowest in the winter due to 
differences in sun exposure (57). Random measurement error can bias the effect 
estimates (for example the regression slope coefficient) towards the null, a phenomenon 
known as attenuation or regression dilution bias (148). This bias occurs when the random 
measurement error is in the exposure variable.  
Systematic error is when the measurement error, does not average out to zero, after 
multiple measurements. The measurements are consistently wrong in a particular 
direction (148). We expect minimal systematic measurement errors because of extensive 
standardization and re standardization exercises of the teams who assessed infections and 
cognitive development. All laboratory instruments, weighing scales, and infantometers 




Confounding occurs when an apparently causal relationship between an exposure and an 
outcome is distorted by the effect of a third variable (the confounder) (149). 
Multivariable regression method is one of the few ways to minimize confounding (149). 
The common approach to build a statistical model is minimization of variables till the 
most parsimonious model is achieved. We used the purposeful selection of covariate 
method for selecting potential confounders in the multivariable regression models. The 
main advantage of this method is that it offers a systematic approach for selecting 
potential confounding variables (150). However, this method was designed to identify 
significant predictor variables of a dependent variable and not to adjust for confounding 
for one specific exposure.  Moreover, the purposeful selection process was not designed 
to include all dummy variables in the model (for example, one variable that has three 
nominal levels which corresponds to two dummy variables which need to be considered 
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as a unit in model inclusion), if one is significant (150). It is important to keep in mind 
that regardless of the variable selection method employed, positive or negative residual 
confounding can’t be ruled out.  
We did not have information on the status of other nutrients that are associated with 
increased risk of diarrhea and pneumonia among the infants, and young children.   
Moreover, there are several other non-nutritional factors linked to vitamin D status that 
may confound the observed associations. The residual confounding can both be because 





Although an important problem, poor precision is usually less of concern than systematic 
errors because it is less likely to distort the findings or reverse the overall direction. 
However, poor precision decreases the probability of finding a real association by 
reducing the statistical power of a study (148). We calculated that we had more than 80% 
power to detect at least 25% increased incidence of ALRIs during the six months follow-
up in the vitamin D deficient children compared to the vitamin D non-deficient children 
with the available sample, at a 5% significance level. It should be noted that the power to 
detect an association between vitamin D deficiency and diarrhea and clinical pneumonia 
was lower than the power to detect its association with ALRIs.  When we estimated the 
statistical power, we assumed minimal random errors in both the exposure and outcome 
variables. This assumption might not have been correct and led to loss of power both 
through attenuated effect estimates and poorer precision.  
 
External validity 
The thesis consists of secondary data analyses from a well-conducted randomized 
controlled trial (RCT) and its follow up study. The high prevalence of vitamin D 
deficiency among the infants and young children could be generalizable to any urban 
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slum population of India as well as to other LMICs in the tropics where atmospheric 
pollution is high, and there are restrictions to outside activities, especially in winters. Our 
results should provide a valuable addition to the existing evidence of the role of vitamin 
D status during infancy and early childhood on common childhood infection, anemia, 
growth, and neurodevelopment. The study setting was characterized by a wide range of 
factors known to be associated with compromised child well-being such as low 
socioeconomic status, high prevalence of undernutrition, widespread deficiency of 
micronutrients critical for growth and neurodevelopment, and high incidence of 
childhood illnesses. The findings from this study may not be generalizable to any larger 




The main strength of the thesis is that it is a secondary data analysis from a well-
conducted RCT with a low attrition rate. We measured vitamin D concentration during a 
critical window of child growth and development. All outcomes were clearly defined and 
measured by trained and supervised workers and psychologists. There were multiple 
follow up visits (twice weekly for 26 weeks) for assessing ALRIs, clinical pneumonia, 
and diarrhea through active surveillance which allowed a minimal recall bias. In the 
follow up, some of the neurodevelopment outcomes were assessed using validated tools 
with Indian norms at an age when cognitive outcomes are considered to be more stable, 
and with greater predictive value (152, 153). All effect sizes were estimated after 
adjustment for several relevant confounders.  
 
Limitations 
An immunoassay method was used to assess vitamin D concentration. The immunoassay 
can underestimate serum 25(OH) D concentration compared to the gold standard liquid 
chromatography-tandem mass spectrometry (LC-MS/MS) (154). Approximately, 85% of 
25(OH)D is bound to VDBP, 15% to albumin, and 0.03% is free (155). Automated 
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immunoassays are based on non-denaturing conditions to free 25(OH)D from VDBP, and 
other serum binding components to allow its binding either to the kit antibodies or 
VDBP. This process may yield varying results because of matrix effects. Thus, the 
immunoassay method might overestimate the prevalence of vitamin D deficiency.  
We translated the ASQ-3 questionnaires for this study, but the alpha values indicated 
questionable internal consistency in some subscales. We could have improved the alpha 
values by pilot testing. However, more than 30% of the variability of ASQ-3 scores was 
explained by the incidence of diarrhea and pneumonia, linear and ponderal growth, 
socioeconomic status and stimulation and learning during early childhood which indicate 
that the translated and adjusted ASQ-3 test had good convergent validity (156). In the 
follow up, the WISC and CVS have been validated for the Indian setting, but this is not 
the case for BRIEF and NEPSY. Type II errors can be due to inadequate sample sizes for 




The declaration of Helsinki of ethical principles for medical research involving human 
subjects, guides all medical research in human subjects worldwide (157). The basic 
principle for this declaration is the fundamental respect for human beings, as well as the 
investigators' sole duty to promote and safeguard the health of the participant. While 
there is always a need for new research, respect for the individual's well-being should 
precede the interest of science and society.  
The research questions for the current thesis are from a well-conducted RCT, and its 
follow up study on the association between vitamin D status, and common childhood 
infection, anemia, growth, and development. The consent form for the original study and 
follow up study also sought permission from parents to store these children's blood 
samples for use for future research. All parents consented for the same.  
Principle number 19 in the Helsinki declaration states that: Medical research is only 
justified if there is a reasonable likelihood that the populations in which the research is 
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carried out stand to benefit from the results of the research. Currently, India does not 
have any national program for vitamin D supplementation for infants, young children, 
and school-age children. We need more evidence to show the adverse effects of vitamin 
D deficiency in the context of urban slum children who are a vulnerable segment of 
society. The current study is of interest to the individual participating child, as well as for 
children on a societal level.  
 
Conclusions  
We have shown that vitamin D deficiency is common in young children in an urban slum 
of New Delhi. Vitamin D deficiency is associated with a higher risk of ALRIs and 
moderate anemia, but not with linear growth and neurodevelopment during early 
childhood and at school age. Our results imply that vitamin D is one of the critical 
micronutrients for common infections and anemia during early childhood. However, we 
believe that vitamin D may have a negligible role in growth and neurodevelopment in the 
light of other growth and development limiting factors in this population. Thus, a 
comprehensive approach should be taken to improve the growth and neurodevelopment 
of young children in South Asia and vitamin D status may not be a critical factor in this 
effort.  
Future perspectives 
The protective role of vitamin D on ALRIs and anemia needs to be confirmed in 
randomized controlled trials especially in vitamin D deficient children.This will help to 
understand more comprehensively the extra-skeletal roles of vitamin D. The biological 
interactions of vitamin D with other growth and development relevant nutrients should 
also be explored in the context of LMICs.    
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Recent studies have demonstrated a relationship between poor vitamin D status and respi-
ratory infections and diarrhea among young children. Acute lower respiratory infections
(ALRI) and diarrhea are among the two most important causes of death in under-5 children.
In this paper, we examined the extent to which vitamin-D deficiency (<10 ng/ml) predicts
ALRI, clinical pneumonia and diarrhea among 6 to 30 months old children.
Methods
We used data from a randomized controlled trial (RCT) of daily folic acid and/or vitamin B12
supplementation for six months in 6 to 30 months old children conducted in Delhi, India.
Generalized estimating equations (GEE) were used to examine the associations between
vitamin-D deficiency and episodes of ALRI, clinical pneumonia and diarrhea.
Results
Of the 960 subjects who had vitamin-D concentrations measured, 331(34.5%) were vita-
min-D deficient. We found, after controlling for relevant potential confounders (age, sex,
breastfeeding status, wasting, stunting, underweight, anemia status and season), that the
risk of ALRI was significantly higher among vitamin-D deficient (OR 1.26; 95% CI: 1.03 to
1.55) compared to vitamin-D-replete children in the six months follow-up period. Vitamin-D
status was not associated with episodes of diarrhea or clinical pneumonia.
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Conclusion
Vitamin-D deficiency is common in young children in New Delhi and is associated with a
higher risk of ALRI. The role of vitamin D in Indian children needs to be elucidated in further
studies.
Introduction
Vitamin D deficiency is considered to be the most common nutritional deficiency and often
one of the most commonly undiagnosed medical conditions in the world [1]. The prevalence
of vitamin D deficiency in young children is around 50–90% in the Indian subcontinent [2].
Vitamin D is primarily produced in the skin after exposure to ultraviolet radiation and less
than 10% is derived from dietary sources [3].
Vitamin D is a potent immune-modulator of adaptive and innate immune responses [4]. In
vitro studies have shown that 1,25-dihydroxyvitaminD3, the active metabolite of vitamin D, is
important for promoting and regulating immune responses [5,6]. Observational studies sug-
gest a link between low vitamin D concentrations and an increased risk of lower and upper
respiratory tract infections in infants and young children [7]. A recent prospective cohort
study found that vitamin-D deficiency was associated with increased rates of diarrheal illnesses
among school-aged children [8]. However, the extent to which vitamin D deficiency predicts
these infections in young children is less clear.
The estimated incidence of pneumonia in children under 5 years is 0.29 episodes per child-
year in developing countries, resulting in 151 million new episodes each year, of which 7–13%
of cases are severe enough to be life-threatening and necessitate hospital admission [9]. In
2013, 25.3% of deaths in children aged 1–59 months in India were due to pneumonia, totaling
150,169 deaths [10]. Globally, diarrhea causes 9% of all under-5 deaths, most of these in devel-
oping countries [10]. Although a reduction has been observed in the incidence of diarrhea in
resource-limited settings, the disease burden associated with recurrent enteric illnesses still
remains a public health problem [11–12] that results in excess childhood mortality [13–15].
Several micronutrients are important for innate and adaptive immunity in young children
[16]. Recent meta-analyses have demonstrated a 15% reduction in childhood diarrheal inci-
dence following vitamin-A supplementation [17] and 13% reduction in diarrheal and pneu-
monia incidence following zinc supplementation [18, 19]. The role of Vitamin-D as an
immune-modulator has led to an increased interest in investigating its function in infectious
diseases [20].
We conducted a randomized controlled trial (RCT) where children aged 6 to 30 months
were supplemented daily with folic acid and/or vitamin B12 for six months. The main out-
comes were the incidence of respiratory infections (ALRI, clinical pneumonia) and diarrhea.
Enrolled participants were followed biweekly for respiratory and diarrheal morbidity [21].
Using data from this study we examined the extent to which vitamin-D deficiency (<10 ng/
ml) at baseline predicted these outcomes during the 6 months follow-up period.
Materials and methods
Subject
The study was conducted from January 2010 to February 2012 in the low-to-middle socioeco-
nomic settings of Tigri and Dakshinpuri in New Delhi. The total population of this site was
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about 300,000. Details of the population have been described previously [21]. This randomized
double-blind placebo-controlled trial (NCT00717730 at www.clinicaltrials.gov) with a factorial
design enrolled 1000 children, and evaluated the impact of supplementation with folic acid,
vitamin B12, or both on childhood infections [21]. The analyses in the current manuscript are
restricted to the group of 960 children whose baseline vitamin-D levels were available.
Definitions
Diarrhea was defined as the passage of 3 or more loose or watery stools in a 24-h period. Two
episodes of diarrhea were separated by a 72-hour or more diarrhea free period. ALRI was
defined as cough or difficult breathing with an elevated respiratory rate above the age-specific
cutoff values ( 50 breaths/min in infants and 40 breaths/min in older children) according
to WHO criteria, or cough or difficult breathing and lower chest in drawing [22]. Clinical
pneumonia was defined either by a combination of cough with crepitations or bronchial
breathing by auscultation or as an episode of ALRI associated with at least one of the following
features: lower chest indrawing, convulsions, inability to drink or feed, extreme lethargy, rest-
lessness or irritability, nasal flaring, or abnormal sleeping and difficulty in waking.
Analytical procedures
Blood samples were obtained at baseline from all the children; 3 mL blood was collected in an
evacuated tube containing EDTA (Becton Dickinson). The plasma was centrifuged at ~
450 × g at room temperature for 10 min, separated, and transferred into storage vials and
stored at– 20˚C until analyzed. Plasma concentration of vitamin-D was measured by quantita-
tive electro-chemiluminescence binding assay, with detection of 25(OH) D2, the hydroxylated
forms of vitamin D2 (Roche Diagnostics, Mannheim, Germany) [23] at Christian Medical Col-
lege, Vellore biochemistry laboratory.
Ethics
This study was conducted according the guidelines laid down in the Declaration of Helsinki.
All procedures were approved by the Ethics committees of the Society for Applied Studies,
New Delhi, Christian Medical College Vellore and Norwegian Regional Committee for Medi-
cal and Health Research Ethics (REK VEST). The consent form for the main trial also sought
permission from parents to store these children’s blood specimen for use in future research.
All parents consented for the same.
Statistical analysis
Proportions and means (SD) or median (IQR) were calculated for categorical and continuous
variables by Vitamin-D status at baseline. Vitamin D deficiency was defined at<10ng/mL (25
nmol/L) [24]. The 6 months’ follow-up period was divided into 26 periods of 7 d for every
child. For a period to be included in the analyses, we required information on 4 d or more
days of the given 7 d period. To account for interdependence of multiple observation periods
in the same child, we used generalized estimating equations (GEE) with an autoregressive
covariance-variance matrix taking time into account. In these models, occurrence of a new
episode of diarrhea, ALRI, or clinical pneumonia in a child period was modeled as dependent
variables and baseline vitamin D status as an independent variable. We included types of inter-
vention received and other baseline variables as independent variables (age, sex, breastfeeding
status, wasting, stunting, underweight, anemia status and season) in the model to adjust for
potential confounding. The model used a logit link, binomial variance, autoregressive
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correlation and robust standard error to yield odds ratio (OR). We used STATA version 14
(Stata Corporation, College Station, TX) for most statistical analyses. We used generalized
additive models in the statistical software R version 3.1.2 (The R Foundation for Statistical
Computing, Vienna, Austria) to explore nonlinear associations between the vitamin D level at
baseline and ALRI incidence after adjustment for potential confounders [25]. We also used
generalized additive models to explore nonlinear associations between vitamin D level at base-
line and season defined by period of enrollment in weeks. We considered an association to be
statistically significant when the P value was <0.05. Post-hoc calculations of statistical power
showed that we had more than 90% power to detect at least 25% more episodes of ALRI during
6 months follow-up in the vitamin- D deficient group compared to vitamin-D non deficient
group with the available sample, at 5% significance level.
Results
A total of 1000 children were included in the main trial. Blood samples for vitamin D were col-
lected at baseline for 960 (96%) children. Of these, 331 (34.5%) children were Vitamin D defi-
cient (<10 ng/ml). The baseline characteristics of the population by deficiency status are
presented in Table 1. Approximately half of the enrolled children were boys and almost all
(98%) were ever breast fed. Over 36.4% of the children were stunted, 31% underweight, and
10.7% wasted. Approximately 70% of the children were anemic.
Fig 1 shows the relationship between vitamin-D according to weeks of enrolment. As dis-
tinct seasons are difficult to define in India, we divided the period of enrollments into weeks.
The vitamin D concentrations were higher in the 24th to 32nd weeks which correspond to
months (May- July) with more daylight. The baseline vitamin D levels were lower for children
who were enrolled in the initial weeks of the year which correspond to months (January-Feb-
ruary) and have less daylight.
The diarrheal episodes in vitamin-D deficient and non-deficient children are shown in
Table 2. There was no association between vitamin-D status and episodes of diarrhea overall
and according to episodes of diarrhea lasting 6 days or more. The association between vita-
min-D status and ALRI and clinical pneumonia are shown in Table 3. The incidence of ALRI
was significantly higher among vitamin-D deficient children than in vitamin-D replete chil-
dren (OR: 1.26; 95% CI: 1.03–1.55). However, the incidence of clinical pneumonia was not sig-
nificantly associated with vitamin D status (OR: 1.05; 95% CI: 0.79–1.38).
The association between baseline vitamin-D levels and incidence density of ALRI is
depicted in Fig 2. The ALRI incidence density increases with decreasing baseline vitamin-D
concentrations.
Discussion
We report the prevalence of vitamin D deficiency and its association with common infections
in young children. We found a high prevalence of vitamin D deficiency which is consistent
with other studies in India [2]. However, a recent study from Nepal found that only<5% of
breastfed infants were vitamin-D deficient, even when a higher cut off (<20 ng/l) was used
[26]. High prevalence of vitamin-D deficiency observed in our study setting, in spite of abun-
dant sunlight may be because of relatively high solar zenith angle, in combination with atmo-
spheric pollution, type- V skin types of the population and restricted outside activities [27, 28].
More Ultraviolet B (UVB) photons are absorbed by the stratospheric zone, and therefore fewer
UVB photons penetrate to earth’s surface to produce cutaneous pre-vitamin D3 with a rela-
tively high solar zenith angle. [29]. A recent study indicated that infants may get enough vita-
min D from breast milk if their mothers take high-dose vitamin D supplements [30]. The
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complementary foods in the diets of Indian infants and children are primarily cereal based
and low in vitamin D [31]. This is probably another contributing factor of the widespread vita-
min-D deficiency among children in this setting.
We found a significantly higher incidence of ALRI among vitamin-D deficient children
when compared to vitamin-D replete children. Similar findings have been shown in previous
observational studies [32–34]. Vitamin-D induces TLR activation and antibacterial responses
which in turns enhances production of cathelicidin (LL-37), an endogenous antimicrobial
peptide which is highly expressed at natural barrier sites e.g. lungs [35]. The protective role of
vitamin-D against ALRI can be explained through its modulatory effect of both innate and
adaptive immunity and regulatory function of inflammatory cascade [36–39].
We did not find any association with clinical pneumonia, a severe form of ALRI, and vita-
min D status. Other observational studies have shown mixed results; while some studies
found associations between vitamin-D status and clinical pneumonia, others did not [40–43].
Table 1. Baseline characteristics of Vitamin D deficient and non deficient children aged 6–30 months
included in the analysis.
Characteristics n = 960
Proportion of children
Deficient (< 10 ng/ml) 331 (34.5)
Non deficient ( 10 ng/ml) 629 (65.5)
Deficient Non deficient
n = 331 n = 629
Infant characteristics
Age at enrollment in months, mean (SD) 16.9 (7.1) 15.8 (7.0)
Proportion of children
<12 months 91 (27.5) 210 (33.4)
12 to 23 months 166 (50.1) 306 (48.7)
24 to 30 months 74 (22.4) 113 (18.0)
Boys 162 (48.9) 328 (52.2)
Ever breastfed 325 (98.2) 622 (98.9)
Prevalence of illness in previous 24 hours
Diarrhea 17 (5.1) 32 (5.1)
Cough or difficult breathing or fast breathing 114 (34.4) 192 (30.5)
Anthropometric status
Mean(SD): Z score
Weight for Height Z score(WHZ) -0.86 (0.92) -0.89 (0.94)
Height for Age Z score (HAZ) -1.56 (1.24) -1.63 (1.16)
Weight for Age Z score (WAZ) -1.46 (1.06) -1.52 (1.05)
Wasted (<-2 WHZ) 35 (10.6) 68 (10.8)
Stunted (<-2 HAZ) 117 (35.3) 233 (37.0)
Underweight (<-2 WAZ) 101 (30.5) 197 (31.3)
Anemia (Hb<11g/dl) 244 (73.7) 424 (67.4)
Socio-demographic characteristics
Mother’s age in years, mean (SD) 26.3(5.8) 25.6(4.1)
Mother’s schooling in years, median (IQR) 8(5,10) 7(0,10)
Father’s schooling in years, median (IQR) 10 (7,12) 9 (6,12)
Annual family income in rupees, median (IQR) 72000 (60000–144000) 84000 (60000–138000)
Figures are number (percentage) unless stated otherwise
doi:10.1371/journal.pone.0170509.t001
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Vitamin D has distinct effects on the innate and adaptive immune responses that may explain
different roles in pathogen-specific infection severity [44]. Furthermore, a recent systematic
review concluded that there was no evidence of vitamin D supplementation among under-5
children in the management of clinical pneumonia [45]. Even if vitamin D has a role in the
defense against infections it might not have a therapeutic role as once an infection has taken
Fig 1. Associations between vitamin-D level at baseline and weeks of a year (among 960 children). The graph was constructed
using generalized additive models in R, the solid line depicts the association of vitamin-D level at baseline and season. The shaded
area spans the 95% confidence interval of this association.
doi:10.1371/journal.pone.0170509.g001
Table 2. Incidence of diarrheal episodes in vitamin-D deficient and non deficient children.
Deficient Non Deficient OR (95% CI)b
(Vitamin D level < 10 ng/ml) (Vitamin D level 10 ng/ml)a
Total child-years of follow-up 162.3 308.5
Episodes of diarrhea 775 1385
Incidence density of diarrhea per child year (95% CI) 4.78 (4.44 to 5.12) 4.49 (4.26 to 4.73) 1.07 (0.95 to 1.20)
Episodes of diarrhea lasting
> = 3 d 328 568 1.07 (0.96 to 1.19)
> = 5 d 182 339 0.98 (0.83 to 1.15)
> = 7 d 114 218 0.95 (0.76 to 1.20)
> = 14 d 34 63 1.01 (0.63 to 1.61)
Episodes of diarrhea with > = 6 stools/on any day 200 409 1.01 (0.83 to 1.22)
a Reference category: Non Deficient (Vitamin D level 10 ng/ml)
b ORs were calculated by using generalized estimating equations with a logit link, binomial variance, autoregressive correlation and robust standard error
and adjusted for age, sex, breastfeeding status, wasted, stunted, underweight, anemia status, season and type of interventions
doi:10.1371/journal.pone.0170509.t002
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place, other factors determine its course and how quickly it will resolve. Given the complexity
of interaction of vitamin-D with the immune system and inflammatory cascade, more research
is needed to further define the specific role of vitamin D in enhancing immune function and
reducing the severity of infections.
Table 3. Incidence of ALRI and clinical pneumonia in vitamin-D deficient and non deficient children.
Deficient Non Deficient OR (95% CI)b
(Vitamin D level < 10 ng/ml) (Vitamin D level 10 ng/ml)a
Total child-years of follow-up 162.3 308.5
Episodes of ALRI 244 418
Incidence density of ALRI per child year (95% CI) 1.50 (1.32 to 1.70) 1.35 (1.23 to 1.49) 1.26 (1.03 to 1.55)
Episodes of clinical pneumonia 144 294
Incidence density of clinical pneumonia per child year (95% CI) 0.89 (0.75 to 1.04) 0.95 (0.85 to 1.07) 1.05 (0.79 to 1.38)
a Reference category: Non Deficient (Vitamin D level 10 ng/ml)
b ORs were calculated by using generalized estimating equations with a logit link, binomial variance, autoregressive correlation and robust standard error
and adjusted for age, sex, breastfeeding status, wasted, stunted, underweight, anemia status, season and type of interventions
ALRI, acute lower respiratory infection
doi:10.1371/journal.pone.0170509.t003
Fig 2. Associations between vitamin-D level at baseline and ALRI incidence density (among 960 children). The graph was
constructed using generalized additive models in R, the solid line depicts the association of vitamin-D level at baseline and ALRI
incidence density. The shaded area spans the 95% confidence interval of this association.
doi:10.1371/journal.pone.0170509.g002
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Poor vitamin D status was not associated with an increased incidence and severity of diar-
rhea in our study, which is in line with findings from another observational study [46]. A ran-
domized controlled trial with 3-monthly bolus supplementation with 100,000 IU of vitamin
D3 among children aged 1 to 29 months, showed no effect on diarrheal illnesses [47]. Our
study was done in urban slum where constant exposure to pathogenic organisms and subse-
quent enteric infection is common in children [48]. This could masquerade the potential bene-
ficial role of vitamin-D in this population.
There may be deficiencies of other limiting micronutrients. Zinc deficiency increases the
risk of diarrhea and pneumonia. A previous study in this population showed that zinc defi-
ciency is common and zinc supplementation reduces the burden of diarrhea and lower respi-
ratory tract infections [49,50]. It has been shown that vitamin-D-depenent genes in the cell are
influenced by the intracellular zinc concentration [51]. Because the sources of vitamin D and
zinc are different, we do not believe that vitamin D status is confounded by zinc status. How-
ever, there is a possibility that these nutrients may interact with each other.
The strengths of our study are that the data are from a well conducted study with very low
attrition rates. We undertook multiple follow up visits for assessing ALRI, clinical pneumonia
and diarrhea to ensure that virtually all episodes were documented. Outcomes were clearly
defined and assessed by highly trained field staff. Results were adjusted for several relevant
confounders including nutritional status of children and the season of enrollment.
We used an immunological method to measure vitamin-D concentration. It should be
noted that immunoassays can overestimate 25OHD [52] because it is lipophilic which makes it
vulnerable to matrix effects in the protein binding assays [53].
The results of this study could have important public health implications. As fortified foods
have been recognized as an important source of vitamin D [54] such as oils, cereal powders
and even salt supplementation and fortification may help in preventing vitamin D deficiency.
Vitamin D supplementation is recommended in many countries, such public health interven-
tions need serious consideration in the Indian context.
Conclusion
The present study demonstrates that vitamin D deficiency is common in New Delhi children
aged 6–30 months and that it is associated with increased risk of ALRI. Randomized controlled
trials measuring the effect of vitamin D supplementation in these setting should be prioritized.
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Objectives: The aim of this study was to examine the association between vitamin D deficiency and anemia
status among young children in the resource-poor setting of northern urban India.
Methods: We used data from a randomized controlled trial of daily supplementation with folic acid, vitamin
B12, or both for 6 mo in children 6 to 30 mo of age conducted in Delhi, India. We measured serum vitamin D
status, hemoglobin, plasma vitamin B12, folate, soluble transferrin receptor, and homocysteine levels at base-
line. Children with severe anemia (hemoglobin [Hgb] <7 g/dL) were excluded from enrollment. Multivariable
logistic and multinomial logistic regressions were used to examine the association between vitamin D and
anemia status at baseline.
Results: 25-Hydroxyvitamin-D (25 OHD) concentration was measured for 960 (96%) children. Of the children,
331 (34.5%) were vitamin- D12X X deficient (<10 ng/mL). Approximately 70% of the enrolled children were anemic,
with »46% having moderate (Hgb 79.9 g/dL) and 24% mild (Hgb 1010.9 g/dL) anemia. There was no asso-
ciation between vitamin D and anemia status after adjusting for confounders; however, the risk for moderate
anemia was significantly higher among vitamin D-deficient children than those who were D13X Xvitamin D14X X-D replete
(relative risk, 1.58; 95% confidence interval, 1.092.31).
Conclusions: Vitamin D deficiency was associated with moderate anemia among young children and the
effect was independent of iron deficiency. The causal association of vitamin D deficiency with anemia risk
remains debatable. The role of vitamin D in risk for anemia needs to be examined in further studies.





Young North Indian children
Introduction
Vitamin D deficiency is one of the most common nutritional
deficiencies and undiagnosed medical conditions in the world [1].
The prevalence of vitamin D deficiency in young children is »50%
to 90% in the Indian subcontinent [2]. Vitamin D is primarily pro-
duced in the skin after exposure to ultraviolet radiation and <10%
is derived from dietary sources [3].
25-Hydroxyvitamin D [25(OH)D], the main circulating form of
vitamin D, is now gradually more accepted for its role in immune
function, cell proliferation, and differentiation in addition to bone
and mineral metabolism [4,5]. This extraskeletal action of vitamin
D usually has been grouped into three major effects: hormone
secretion control, immune function modulation, and control of cel-
lular proliferation and differentiation [4].
Recent studies suggest that 25(OH)D deficiency is associated
with increased risk for anemia, an important public health problem
experienced by as many as 50% of Indian children [4,6]. Lower 25
(OH)D levels have been independently associated with anemia in
adults with chronic diseases such as heart failure, diabetes, and
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chronic kidney disease (CKD) [711], even among healthy
adults [12]. However, there is a scarcity of data on the association
between vitamin D and anemia status in young children.
We conducted a randomized controlled trial (RCT) with children
6 to 30 mo of age. The children were supplemented daily with folic
acid, vitamin B12, or both for 6 mo. Using data from this study, we
examined the association between vitamin D and anemia status in
young children from a resource-poor setting in northern urban India.
Materials and methods
Participants
The study was conducted from January 2010 to February 2012 in the low to
middle socioeconomic settings of Tigri and Dakshinpuri in New Delhi, India. The
total population of this site was »300 000. Details of the population have been
described previously [13]. This randomized, double-blind, placebo-controlled trial
with a factorial design enrolled 1000 children, and evaluated the effects of supple-
mentation with folic acid, vitamin B12, or both on childhood infections [13]. Chil-
dren with severe systemic illness requiring hospitalization, severe malnutrition
(weight-for-height Z-score <3), or severe anemia (Hgb <7 g/dL), those on folic
acid or vitamin B12 supplements, and those not consenting or considering migra-
tion were excluded from enrollment. A blood specimen was obtained in EDTA-con-
taining vacutainers (BD, Franklin Lakes, NJ, USA) for all children at baseline.
Definitions
Anemia was defined on the basis of World Health Organization criteria [14] as
follows:
 Mild anemia = Hgb 10 to 10.9 g/dL
 Moderate anemia = Hgb 7 to 9.9 g/dL
 Severe anemia = Hgb <7 g/dL
Iron deficiencywas defined as soluble transferrin receptor (sTfR) concentrations
>4.7 nmol/L [15]. We defined vitamin B12 deficiency as plasma vitamin B12 level
<200 pmol/L and folate deficiency as a plasma folate level of <7.5 nmol/L [16].
We defined high homocysteine (Hcy) level as plasma Hcy level 10 mmol/L [17].
Vitamin D deficiencywas defined as<10 ng/mL (25 nmol/L) [18]. We also conducted
a sensitivity analysis classifying baseline vitamin D status as<10, 11 to 20, 21 to 29,
and30 ng/mL.
Analytical procedures
The blood specimen was centrifuged (Remi Sales & Engineering Ltd, Mumbai,
India) at »450g at room temperature for 10 min in field settings. Plasma was sepa-
rated, transferred into storage vials, and stored at 20°C at the central laboratory
until analysis. HemoCue AB (HemoCue Hb Angelholm, Sweden) was used to ana-
lyze Hgb concentration [19,20]. Plasma concentrations of folate and vitamin B12
were estimated by microbiologic assays [21,22], and plasma sTfR was analyzed
using an immunoturbidimetric assay [23]. Plasma total homocysteine (tHcy) was
analyzed using commercial kits (Abbott Laboratories, Abbott Park, IL, USA) [24].
Plasma concentration of vitamin D was measured by quantitative electrochemilu-
minescence binding assay, with detection of 25(OH) D2, the hydroxylated forms of
vitamin D2 (Roche Diagnostics, Mannheim, Germany) [25].
Ethics
This study was conducted according to the guidelines laid down in the Decla-
ration of Helsinki. All procedures were approved by the ethics committees of the
Society for Applied Studies, New Delhi, Christian Medical College Vellore and Nor-
wegian Regional Committee for Medical and Health Research Ethics (REK VEST).
The consent form for the main trial also sought permission from parents to store
their children's blood specimen for use in future research. All parents consented
for the same.
Statistics
Proportions, means (SD), or medians (interquartile range [IQR]) were calcu-
lated for categorical and continuous variables by anemia status at baseline.
We had conducted a dominance analysis to show the relative importance of differ-
ent erythropoietic nutrients (folate, vitamin B12, sTfR) on Hgb status.
We used multiple regression and a “purposeful selection of covariates
method” to identify variables that were associated with vitamin D deficiency and
different types of anemia [26,27]. These variables were used as adjustment varia-
bles in the multiple models where vitamin D deficiency was the exposure variable.
We also examined whether the predefined associations were modified by other
Table 1
Baseline characteristics of anemic and non-anemic children 6 to 30 mo of age included in the analysis (N = 1000)*
Characteristics
Proportion of children
No anemia 304 (30.4)
Anemia 696 (69.6)
No anemia (Hgb 11 g/dL) Anemia(Hgb <11 g/dL)
n = 304 n = 696
Infant characteristics
Proportion of children
<12 mo 131 (43.1) 190 (27.3)
1223 mo 115 (37.8) 369 (53)
2430 mo 58 (19.1) 137 (19.7)
Boys 150 (49.3) 357 (51.3)
Ever breastfed 252 (83.2) 546 (78.9)
Anthropometric status
Wasted (<2 WHZ) 29 (9.54) 76 (10.9)
Stunted (<2 HAZ) 80 (26.3) 285 (40.9)
Sociodemographic characteristics
Mother's schooling, y (median, IQR) 8 (5,12) 6 (0,9)
Annual family income, rupees (median, IQR) 104 000 (60 000180 000) 72 000 (48 000120 000)
Biochemical status






















HAZ, height-for age Z-score; Hgb, hemoglobin; IQR, interquartile range; WHZ, weight-for-height Z-score.
*Values are number (percentage) unless stated otherwise.
64 R. Chowdhury et al. / Nutrition 57 (2019) 6368
variables using interaction terms (on a multiplicative scale) in the multiple regres-
sion models.
Multiple logistic regression analyses were used to compare the anemia status
(anemia and no anemia) between the vitamin D-deficient and the non-deficient
groups at baseline. In these models, we adjusted for age of the child, family
income, mothers’ years of schooling, stunted, season, baseline plasma folate,
plasma sTfR, and plasma Hcy level.
We used multinomial logistic regression analyses to measure the association
between vitamin D deficiency and different categories of anemia (mild, moderate)
compared with no anemia at baseline. In these models, we adjusted for age of the
child, family income, mothers’ years of schooling, stunted, season, baseline plasma
folate, plasma sTfR, and plasma Hcy level. Statistical analyses were performed
using STATA version 15 (Stata Corporation, College Station, TX, USA).
We used generalized additive models in the statistical software R version 3.1.2
(The R Foundation for Statistical Computing, Vienna, Austria) to explore non-linear
associations between the vitamin D status and Hgb level at baseline after adjust-
ment for potential confounders [28].
Results
We included 1000 children in the main trial. Vitamin D concen-
tration was available in 960 baseline samples. Of the children 331
(34.5%) were vitamin D deficient (<10 ng/mL). The baseline charac-
teristics of the population by anemia status are presented in
Table 1. Approximately 70% of the enrolled children were anemic,
with »46% having moderate anemia and 24% having mild anemia.
Approximately 40% of the anemic children were stunted (height-
for-age Z-score <2) and had higher plasma sTfR concentration
(>4.7 nmol/L).
The prevalence of iron deficiency (elevated sTfR i.e., >4.7 nmol/
L) was 31% (n = 309) and elevated sTfR showed highest dominance
(standardized dominance statistics 83%) among folate, vitamin B12,
and sTfR.
The anemia status among vitamin D-deficient and non-deficient
children is shown in Table 2. There was no association between
vitamin D status and anemia after adjusting for confounders. How-
ever, the risk for moderate anemia was significantly higher among
vitamin D-deficient children compared with those who were vita-
min D replete (relative risk [RR], 1.58; 95% confidence interval [CI],
1.092.31). The prevalence of mild anemia was not significantly
associated with vitamin D status (RR, 1.14; 95% CI, 0.771.69).
We also conducted a sensitivity analysis by classifying baseline
vitamin D status as <10, 11 to 20, 21 to 29, and 30 ng/mL. Of the
children, 34.6% had <10 ng/mL, 42.4% had 11 to 20 ng/mL, 17% had
21 to 29 ng/mL, and 6% had 30 ng/mL levels of vitamin D. Anemia
overall and the mild and moderate anemia subgroups were not sig-
nificantly associated with any of the vitamin D category.
The association between vitamin D and Hgb level at baseline is
shown in Figure 1. We restricted the analysis to vitamin D level
40 ng/mL as there were very few children above that level. There
was a non-linear association between vitamin D and Hgb level at
baseline.
Discussion
The present study demonstrated that in a population-based
cohort of young Indian children, lower 25(OH)D levels were associ-
ated with increased risk for moderate anemia. The observed associ-
ation between vitamin D status and moderate anemia was
independent of other factors that may contribute to anemia risk,
including socioeconomic status and nutritional status (including
stunting and iron deficiency).
In recent years, vitamin D has received interest as a regulator of
a variety of biological functions including immune function and
cellular proliferation [2931].
Recent literature showed increased risk for anemia among vita-
min D-deficient children and adolescents; however, most of the
studies were conducted in developed countries. A cross-sectional
study conducted among children and adolescents in the United
States, showed increased odds (odds ratio [OR], 1.9; 95% CI,
1.32.7) of anemia among the vitamin D-deficient population com-
pared with a vitamin D-sufficient population. The effect was inde-
pendent of other confounding factors that could have contributed
to anemia risk, such as obesity, inflammation, socioeconomic sta-
tus, and nutritional status such as vitamin D15X XB12D16X X, folic acid, and iron
deficiency [32]. In another study in South Korea, the authors
showed vitamin D deficiency in a higher proportion of infants with
iron deficiency anemia compared with a vitamin D-replete group
and a significant correlation between Hgb and 25(OH)D levels [33].
In China, Chang et al. showed increased risk for anemia among
vitamin D-deficient children between 6 mo and 14 y of age [34].
None of the studies excluded severe anemic (Hgb <7 g/dL) chil-
dren/adolescent. We did not find any association with vitamin D
deficiency and overall anemia status, possibly because of excluding
severe anemic children from the main trial.
Similar findings were shown in studies done with adult popula-
tion. Lower 25(OH)D levels had been associated with anemia in
adults with non-dialysis CKD, end-stage kidney disease, end-stage
heart failure, and type 2 diabetes [32]. Vitamin D supplementation
among adults with CKD had demonstrated to improve anemia
management and decrease dose requirements for erythropoiesis-
stimulating agents, suggesting that vitamin D plays a role in eryth-
ropoiesis [35,36].
There are several possible mechanisms that could explain our
findings. Vitamin D and its metabolites are present in many tissues,
as are the vitamin D receptors (VDR) for the active form of vitamin
D, calcitriol. Although calcitriol production for the regulation of
bone mineral metabolism takes place via the action of the 1-
a-hydroxylase enzyme in renal tissue, there are multiple extrare-
nal sites where locally produced calcitriol regulates host-cell DNA,
and from which the extraskeletal actions of vitamin D are con-
trolled [4,37]. Inadequate levels of 25(OH)D leading to decreased
Table 2
Prevalence of anemia in vitamin-D deficient and non-deficient children
Deficient (vitamin D level
<10 ng/mL)(n = 331)
Non-deficient (vitamin D
level >10 ng/mL)*(n = 629)
Unadjusted OR (95% CI) Adjusted OR (95% CI)y
Anemia (Hgb <11 g/dL) 244 (73.7) 424 (67.4) 1.35 (1.011.82) 1.35 (0.961.88)
Subgroup
Unadjusted OR (95% CI) Adjusted OR (95% CI)z
Moderate anemia (Hgb 79.9 g/dL) 173 (52.3) 267 (42.4) 1.53 (1.112.09) 1.58 (1.092.31)
Mild anemia (Hgb 1010.9 g/dL) 71 (21.5) 157 (25.0) 1.06 (0.731.55) 1.14 (0.771.69)
Hgb, hemoglobin.
*Reference category: Non-deficient (vitamin D level >10 ng/mL).
yORs were calculated by using logistic regression and adjusted for age, family income, mothers’ years of schooling, stunted, season, baseline plasma folate, plasma soluble
transferring receptor saturation, plasma homocysteine level.
zORs were calculated by using multinomial logistic regression and adjusted age, family income, mothers’ years of schooling, stunted, season, baseline plasma folate, plasma
soluble transferring receptor saturation, plasma homocysteine level.
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local calcitriol production in the bone marrow may limit erythro-
poiesis; calcitriol has a direct proliferative effect on erythroid
burst-forming units, which is synergistic with endogenously pro-
duced erythropoietin, and also upregulates expression of the eryth-
ropoietin receptor on erythroid progenitor cells [34,38,39].
Calcitriol also plays a key role in the regulation of immune function
by inhibiting the expression of proinflammatory cytokines by
a variety of immune cells, thus providing negative feedback to pre-
vent excessive inflammation [4]. The immunomodulatory effects
of vitamin D may be central to its role in preventing anemia via
modulation of systemic cytokine production, which may in turn
suppress specific inflammatory pathways that contribute to the
development of anemia. The role of inflammation in the etiology of
anemia has been further clarified through study of the iron regula-
tory protein hepcidin, an inflammation-induced negative regulator
of erythropoiesis [40,41].
To our knowledge, this is the first study conducted in India
among young children to show the association between vitamin D
deficiency and anemia status. We also assessed the relevant and
important erythropoietic nutrients and its metabolites like plasma
vitamin B12, folate, Hcy (active metabolite of vitamin B12 and
folate) and sTfR (markers of iron deficiency). These assessments
helped us demonstrate the effect of vitamin D deficiency on anemia
status independent of important erythropoietic nutrient. As a
marker of iron deficiency status, we assessed sTfR, a reliable
marker for the diagnosis of iron deficiency, especially when iron
metabolism is influenced by inflammatory disorders such as infec-
tion and chronic inflammation, and thus provide a robust estimate
of iron deficiency status.
The present study had several strengths, including a popula-
tion-based sample of children, standardized data collection, and
quality control procedures. Results were adjusted for several rele-
vant confounders including nutritional status of children and the
season of enrollment.
The present study had some limitations, including type II errors
and weaknesses with the immunologic vitamin D assay. Type II
errors can also be due to low sample size. For the subgroups of vita-
min D categories, there was not sufficient power (<80%). We used
an immunologic method to measure vitamin D concentration. It
should be noted that immunoassays can overestimate 25(OH)D
[42] as it is lipophilic and is therefore vulnerable to matrix effects
in the protein binding assays [43]. However, this is a cross-sec-
tional study, and thus the association between vitamin D deficiency
and anemia cannot be assumed to be causal.
Conclusion
Although the causal association of vitamin D deficiency with
anemia risk (especially iron deficiency anemia) remains debatable,
our analysis showed increased risk for moderate anemia among
vitamin D-deficient children, which was independent of iron defi-
ciency status. RCTs measuring the effect of vitamin D supplementa-
tion on anemia in these setting should be prioritized.
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Abstract
Background: Vitamin-D deficiency has been linked with impaired development in animal studies; however, the
evidence from human studies is scanty. Evidence as to whether vitamin-D deficiency during early childhood affects
growth is also limited and conflicting. We examined the extent to which vitamin-D deficiency (<10 ng/ml) is
associated with neurodevelopment and physical growth in young children.
Methods: We used data from a randomized controlled trial (RCT) of daily folic acid and/ or vitamin B12 supplementation
for six months in children aged 6 to 30 months conducted in Delhi, India. We measured vitamin-D status and
neurodevelopment by the Ages and Stages Questionnaire-3 (ASQ-3) at 12 to 36 months of age. Multiple logistic and linear
regressions were used to examine the association between vitamin-D deficiency at baseline and neurodevelopment
and growth 6 months follow-up.
Results: 25-hydroxy-vitamin-D (25OHD) concentration was measured at baseline for 960 (96%) children. Of these, 331
(34.5%) children were vitamin-D deficient. The total and subscale (except for the Personal social scale) ASQ-3 scores,
were not different between the vitamin-D deficient and non-deficient children. Vitamin-D deficiency was also not
associated with physical growth at baseline and at follow -up.
Conclusion: Our data do not support the hypothesis that vitamin-D deficiency is associated with poor growth and
neurodevelopment.
Trial registration: NCT00717730 and CTRI/2010/091/001090. Date of registration: 08 October, 2010
Keywords: Vitamin-D, ASQ-3, Neurodevelopment, Physical growth, Young north Indian children
Background
Vitamin-D deficiency is considered to be one of the
most common nutritional deficiencies and a commonly
undiagnosed medical condition in the world. [1] The
prevalence of vitamin-D deficiency is 50–90% in the In-
dian subcontinent. [2] Vitamin-D is primarily produced
in the skin after exposure to ultraviolet radiation and
less than 10% is derived from dietary sources. [3]
Poor maternal vitamin-D status during pregnancy has
been linked to impaired neurodevelopment among adult
offspring and to structural changes in the brain such as
enlarged lateral ventricles, thinner cortex, and more cell
proliferation in animal studies. [4, 5] Human studies have
shown that poor vitamin-D status prenatally is associated
with adverse neuropsychiatric outcomes including schizo-
phrenia and child autism. [6, 7] Two recent longitudinal
studies showed a link between maternal vitamin-D status in
early pregnancy and delayed neurocognitive development
including language impairment, mental development, and
psychomotor development in early childhood. [8, 9] To our
knowledge, there are few studies on the association be-
tween vitamin-D status in children and neurodevelopment.
Vitamin-D is required for normal calcification of the
growth plate and bone mineralization. [10] The major
role of vitamin-D in maintaining bone health is to en-
sure normal calcium and phosphate levels in the blood.
Children have higher calcium demands than adults; they
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require a positive calcium balance to assure adequate
calcium for the mineralization of growing bone. [11] It is
therefore important to ensure adequate vitamin-D status
in order to enhance normal calcification of the growth
plate and bone mineralization.
We undertook a randomized controlled trial (RCT) of
daily supplementation with folic acid and/or vitamin
B12 or placebo for six months in 6 to 30 months old
children and measured the 25OHD cocentration in the
blood specimens at baseline and at 6 months follow-up.
We took the opportunity to estimate the association be-
tween baseline and at 6 months follow -up vitamin-D
status and neurodevelopment measured by the Ages and
Stages Questionnaire-3 (ASQ-3) after 6 months as well
as the association between vitamin-D deficiency and
physical growth (wasting, stunting and underweight) at
baseline and 6 months later.
Methods
The study was conducted from January 2010 to February
2012 in the low-to-middle socioeconomic neighbor-
hoods of Tigri and Dakshinpuri in New Delhi, India.
The total population was around 300,000; details of the
population have been described previously [12]. The
current analysis has been done within the framework of
a randomized double-blind placebo-controlled trial
(NCT00717730 at https://clinicaltrials.gov/ct2/show/
NCT00717730) involving supplementation with folic
acid and/or vitamin B12 or placebo for six months to
1000 children who were 6 to 30 months old at enroll-
ment [12]. Vitamin-D status was available for 960 chil-
dren at baseline and in 243 at 6 months follow-up. For
baseline, our analysis for neurodevelopment is restricted
to the 401 children in whom ASQ-3 [13] was adminis-
tered, for physical growth to 960 children in whom an-
thropometry data were available at baseline and to 919
children in whom anthropometry data were available
6 months later. Of the 243 children, neurodevelopment
data were available for 92 children and anthropometry
data were available for all.
Assessment
Neurodevelopment was assessed 6 months after enroll-
ment using the ASQ-3 which is a developmental screen-
ing tool constructed in the USA. [13] The ASQ-3
consists of age-appropriate questionnaires, all containing
30 items divided into five subscales: Communication,
Gross motor, Fine motor, Problem-solving and Personal-
social, summing up to five subscale scores (range 0 to
60) and a total score (range 0 to 300). The construct and
convergent validity of the translated ASQ-3 forms for
the current setting were excellent, and our multiple
models were able to explain more than 30% of the vari-
ability of the ASQ-3 scores. [14]
Details of the Hindi translation and process of valid-
ation of ASQ-3, training and standardization methods
have been described previously. [15] Three trained field
supervisors administered the ASQ-3 directly to the child
at the study clinic in the presence of caregivers. The ex-
aminers elicited the relevant skills from the child during
sessions using standardized materials. The caregiver
served as an important contributor in supporting the
child, eliciting behaviors and gave relevant information
of the child’s development when necessary. During the
11 days of training, the field supervisors were standard-
ized in performing the procedure, and they reached a
high inter-observer agreement both during training and
in the 10% quality control checks throughout the study.
To assess the caregiver’s promotion of child develop-
ment two questions were selected from the standardized
assessment tool Home Observation for Measurement of
the Environment (HOME) that were asked the care-
givers during the session. [16] One question was on
“Mother’s belief that child’s behavior can be modified”
and one was on “Mother’s encouragement of develop-
mental advances”.
Trained field supervisors measured weight and length
at baseline and after six months of supplementation.
Weight was measured to the nearest 50 g using elec-
tronic scale (Digitron scale). Length was measured using
locally manufactured infantometers reading to the near-
est 0.1 cm.
Analytical procedures
Blood samples were obtained at baseline from all children;
3 mL blood was collected in an evacuated tube containing
EDTA (Becton Dickinson). The plasma was centrifuged at
~450×g at room temperature for 10 min, separated, and
transferred into storage vials and stored at −20 0 C until
analyzed. Plasma concentration of vitamin-D was mea-
sured by quantitative electro-chemiluminescence binding
assay, with detection of 25 OHD, the hydroxylated
forms of vitamin-D2 (Roche Diagnostics, Mannheim,
Germany) [17] at the Department of Biochemistry,
Christian Medical College, Vellore, India.
Statistical analysis
Proportions, means (SD) or medians (IQR) were calcu-
lated for categorical and continuous variables by
vitamin-D status at baseline. Though The Institute of
medicine concluded that for maximum bone health a
blood level should be at least 20 ng/mL and the Endo-
crine Society’s Practice Guidelines recommended for
maximum bone health a level should be above 30 ng/
mL, we considered vitamin-D deficiency was defined at
<10 ng/mL (25 nmol/L). [18] We also ran a sensitivity
analysis classifying baseline vitamin-D status as <10, 11–
20, 21–29 and > = 30 ng/mL.
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We used multiple regression and a “purposeful
selection of covariates method” to identify variables that
were associated with vitamin-D deficiency and our pre-
defined outcomes. [19, 20] These variables were used as
adjustment variables in the multiple models where
vitamin-D deficiency was the exposure variable. We also
examined whether the predefined associations were
modified by other variables using interaction terms (on
a multiplicative scale) in the multiple regression models.
Multiple linear and logistic regression analyses were
used to compare the total ASQ-3 and subscale-scores
between the vitamin-D deficient and the vitamin-D non-
deficient groups at baseline and at 6 months followup.
In logistic regression models the total and subscale
ASQ-3 scores were categorized at the 25th percentile. In
these models, we adjusted for age of child, mother’s
years of schooling, father’s years of schooling, log
transformed annual family income, family structure,
number of toys in the family, whether or not the
family owns books, number of children in the family,
hours of play with other children during the week,
mother’s belief that child’s behavior can be modified,
mother’s encouragement of developmental advances,
weight-for-height Z score, weight for-age Z scores
and intervention group.
We used multiple linear and logistic regression ana-
lyses to measure the association between vitamin-D defi-
ciency and childhood physical growth at baseline and at
6 months follow-up. In logistic regression models, phys-
ical growth was categorized as wasting (< −2 Z scores
weight-for-height/length), stunting (<−2 z score height/
length-for-age) and underweight (< −2 Z scores weight-
for-age). In the linear regression models, we used the Z
scores of weight-for-height/length (WHZ), height/
length-for-age (HAZ), weight-for-age (WAZ) as
dependent variables. In these models, we adjusted for
age, sex, breastfeeding status, family structure, log trans-
formed annual family income, mother’s years of school-
ing, father’s year of schooling, baseline level of vitamin
B12, folate and anemia status for baseline physical
growth as well as, intervention group (placebo, folic acid,
vitamin B12, or both) for 6 months later physical
growth.
Statistical analyses were performed using STATA ver-
sion 14 (Stata Corporation, College Station, TX).
We used generalized additive models in the statistical
software R version 3.1.2 (The R Foundation for Statis-
tical Computing, Vienna, Austria) to explore nonlinear
associations between the vitamin-D status at baseline
and HAZ score at baseline after adjustment for potential
confounders [21]. We also used generalized additive
models to explore nonlinear associations between
vitamin-D status at baseline and total ASQ-3 score after
6 months of follow - up.
Results
A total of 1000 children were included in the main trial.
Vitamin-D level was analyzed in baseline samples for
960 (96%) children. Of these, 331 (34.5%) were vitamin-
D deficient (<10 ng/ml). The mean (SD) and median
(IQR) of vitamin-D level were 14.82 (8.7) ng/ml and
13.15 (8.31, 19.2) ng/ml. The baseline characteristics of
the population by vitamin-D status are presented in
Table 1. Approximately half of the enrolled children
were boys and almost all (98%) were ever breast fed. Ap-
proximately 70% of the children were anemic
(Hb < 11 g/dl).
The mean (SD) of the total ASQ-3 and subscales
scores by vitamin-D status are shown in Table 2. The
overall ASQ-3 score was not significantly lower in the
vitamin-D deficient group [mean difference − 6.54 (95%
CI: -16.15 to 3.08)] compared to the vitamin-D non-
deficient group. The Personal social subscale score was
significantly lower in the vitamin-D deficient group
[mean difference − 2.63 (95% CI: -5.00 to −0.25)],
whereas the other subscale scores were not. There was
no interaction on a multiplicative scale between inter-
vention (folic acid and/or vitamin B12 or placebo) and
vitamin-D deficiency on the total ASQ-3 score or for the
subscales scores.
We repeated the analyses using logistic regression after
dichotomizing the outcomes at the 25th percentiles.
After adjusting for potential confounders, we found a
significant difference (OR: 1.63; 95% CI: 1.03 to 2.58) in
the Personal-social subscale. The overall ASQ-3 score
and the remaining subscales were not associated with
vitamin-D deficiency. (Table 3).
Tables 4 and 5 show the distribution of the propor-
tion of children stunted, wasted and underweight ac-
cording to vitamin-D status at baseline and 6 months
later respectively. At baseline in the vitamin-D defi-
cient group, the proportion of stunted, wasted and
underweight children was 35.4%, 10.6% and 30.5% re-
spectively. 6 months later, in the vitamin-D deficient
group the proportion of stunted, wasted and under-
weight children was 37.8%, 13.9% and 32.8% respect-
ively. Vitamin-D deficiency was not associated with
stunting nor wasting nor underweight at baseline or
6 months later in this population.
No substantial or significant differences were found
when we did these analyses using HAZ, WHZ and WAZ
scores as outcome variables both at baseline and
6 months later i.e. vitamin-D deficiency is not associated
with any of the physical growth parameters on a con-
tinuous scale.
We estimated vitamin D status at end study in only
243 children, and the prevalence of deficiency was
38.3%. Of the 243 children neurodevelopment data were
available for 92 children. None of the neurodevelopment
Chowdhury et al. Nutrition Journal  (2017) 16:59 Page 3 of 8
outcomes (Total ASQ-3, sub scales of ASQ-3 i.e. Com-
munication, Gross motor, Fine motor, Problem - solving,
Personal- social), nor any of the grwoth outcomes were
significantly associated with vitamin D status after
6 months (Not shown in table).
We also did a sensitivity analysis by classifying baseline
vitamin-D status as <10, 11–20, 21–29 and > = 30 ng/
mL. 34.6% children were <10, 42.4% were 11–20, 17%
were 21–29 and 6% were above 30 ng/ml. None of the
neurodevelopment outcomes (Total ASQ-3, subscales of
ASQ-3 i.e. Communication, Gross motor, Fine motor, Prob-
lem solving, Personal- social) and growth outcomes (wast-
ing, stunting and underweight at baseline and end study)
were significantly associated with any of these quartiles.
The association between vitamin-D status at baseline
and HAZ score at baseline and total ASQ-3 score after
6 months are depicted in Figs 1 and 2. There was no
association.
Table 1 Baseline characteristics of vitamin-D deficient and non-deficient children aged 6–30 months included in the analysis
Characteristics n = 1000
Number of children for whom samples for vitamin-D were available at baseline 960 (96.0%)
Proportion of children
Deficient (< 10 ng/ml) 331 (34.5)
Non-deficient (≥ 10 ng/ml) 629 (65.5)
Deficient Non-deficient
n = 331 n = 629
Infant characteristics
Age at enrollment, months (mean, SD) 16.9 (7.1) 15.8 (7.0)
Boys 162 (48.9) 328 (52.2)
Ever breastfed 325 (98.2) 622 (98.9)
Anemia (Hb < 11 g/dl) 244 (73.7) 424 (67.4)
Folate, nmol/L (Median, IQR) 9.1 (6.1 to 16.7) 12.5 (6.9 to 21.8)
Vitamin B12, pmol/L (Median, IQR) 266 (181 to 406) 266 (172 to 410)
Socio-demographic characteristics
Mother’s age, years (Mean, SD) 26.3 (5.8) 25.6 (4.1)
Mother’s schooling, years (Median, IQR) 8 (5,10) 7 (0,10)
Literate mother 257 (77.6) 466 (74.1)
Father’s schooling, years (Median, IQR) 10 (7,12) 9 (6,12)
Annual family income, US dollar(Median, IQR)a 1108 (923to 2215) 1292 (923 to2123)
Figures are number (percentages) unless stated otherwise
a1 US Dollar = INR 65











Unadjusted Mean Diff (95% CI)
Total ASQ-3 229.98 (49.76) 236.52 (47.06) −6.54 (−16.15 to 3.08)
Subscale
Communication 49.04 (15.19) 49.26 (15.11) - 0.22 (−3.22 to 2.8)
Gross motor 46.36 (14.39) 48.29 (13.41) −1.93 (−4.69 to 0.82)
Fine motor 46.73 (14.90) 48.89 (12.09) −2.15 (−4.81 to 0.50)
Problem-solving 46.42 (13.97) 46.03 (13.45) 0.39 (−2.33 to 3.12)
Personal social 46.42 (12.04) 49.05 (11.84) −2.63 (−5 to −0.25)*
*p < 0.05
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Discussion
Except for the Personal - social scale, we did not find
any significant differences in the total ASQ-3 and sub-
scale scores between vitamin-D deficient and non-
deficient children. Nor did we find any association be-
tween growth indices and vitamin D deficiency.
Our findings are consistent with those from a re-
cently conductedcohort study in India, where
vitamin-D status was not associated with the gross
motor subscale of ASQ-3 among school- aged chil-
dren [22]. A recent prospective study also suggests
an inverted-U–shaped relation between neonatal
vitamin-D status and neurocognitive development in
toddlers [23]. Recent studies have shown an association
between prenatal vitamin-D deficiency with delayed lan-
guage development in early childhood [24, 25]. However,
the association between vitamin-D deficiency and the
Personal social subscale may very well be a chance
finding considering the number of outcomes exam-
ined. It should also be noted that the personal social
scores is the domain with poorest psychometric
properties. [15]
The ASQ-3 is a screening tool for the assessment of
developmental delay constructed in the US with binary
cut-offs. It has however been used to measure develop-
mental status on a continuous scale in the present study
as in several other studies. [13] Alpha values indicated
questionable internal consistency in a few subscales and
age categories. Poor internal consistency can be due to
constant items (lack of variability of the responses) or
random error which may result in false negative results
(type II error). However, in another publication from this
study we also found that the ASQ-3 scores were associated
with linear and ponderal growth, the incidence of diar-
rhea and pneumonia, as well as socioeconomic status
and stimulation and learning opportunities. In fact, these
variables explained more than 30% of the variability of
the ASQ scores which demonstrates that the translated
ASQ-3 test had good convergent validity. [14] Thus, the
lack of findings of an association between vitamin-D and
Table 3 Odds Ratios for the lower quartile of total ASQ-3 and subscale scores compared with Non-deficient vitamin-D status (≥
10 ng/ml) adjusting for confoundersa
Non-Deficient
(Vitamin-D status ≥ 10 ng/ml)
Deficient
(Vitamin-D status < 10 ng/ml)
OR OR 95% CI
Total ASQ-3 1 1.36 0.79 to2.31
Subscale
Communication 1 1.58 0.97to 2.59
Gross motor 1 1.27 0.80 to 2.03
Fine motor 1 1.31 0.81to 2.11
Problem-solving 1 1.33 0.84to 2.11
Personal - social 1 1.63 1.03to 2.58*
*p < 0.05
aAdjusted for: age of child, mother’s years of schooling, father’s years of schooling, log transformed annual family income, family structure, number of toys in the
family, whether or not the family owns books, number of children in the family, hours of play with other children during the week, mother’s belief that child’s
behavior can be modified, mother’s encouragement of developmental advances, weight-for-height Z score, weight for-age Z scores, anemia status at baseline and
intervention group












HAZ −1.56 (1.24) −1.63 (1.16) .05 (−0.10 to 0.20)
WHZ −0.86 (0.92) −0.89 (0.94) .02 (−0.10 to 0.14)
WAZ −1.46 (1.06) −1.52 (1.05) .03 (−0.10 to 0.17)
Adjusted OR (95% CI)a
Stunted, n (%) 117 (35.4) 233 (37.0) 0.84 (0.63 to 1.13)
Wasted, n (%) 35 (10.6) 68 (10.8) 0.99 (0.64 to 1.54)
Underweight, n (%) 101 (30.5) 197 (31.3) 0.91 (0.67 to 1.23)
aAdjusted for: age, sex, breastfeeding status, log transformed annual family income, family structure, mother’s years of schooling, father’s years of schooling,
baseline levels of vitamin B12, folate, anemia status at baseline
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ASQ-3 scores is probably not due to poor psychometric
properties of the test. In the translated ASQ-3 version, the
standardized alphas for the total ASQ-3 scores were
strong, indicating an overall acceptable internal
consistency.
Type II errors can also be due to low sample size,
negative confounding, and/or weaknesses with the im-
munological vitamin –D assay. We used an immuno-
logical method to measure vitamin-D concentration.
It should be noted that immunoassays can overesti-
mate 25OHD [26] because it is lipophilic which
makes it vulnerable to matrix effects in the protein
binding assays. [27]
We found no association between vitamin-D defi-
ciency and physical growth at baseline and 6 months
later. Similar findings have been described in pre-school
children in Nepal and HIV exposed but uninfected
infants in Africa, where vitamin-D deficiency was not as-
sociated with stunting and underweight, although wasted
children have been found to be more commonly vita-
min- D deficient. [28, 29] However, a recent trial in India
showed that weekly administration of 1 RDA of vitamin-
D supplementation for six months among LBW infants
significantly increased weight and length, and decreased
the proportion of children with stunted growth. [30] In
addition, an observational study of Canadian infants
found higher vitamin - D concentrations during infancy
to 3 years of age were associated with leaner body com-
position. [31]
Although the major role of vitamin-D in maintaining
bone health is to ensure normal calcium and phosphate
levels in the blood, [32] we did not find any association
between vitamin-D deficiency and ponderal or linear
growth.












HAZ −1.69 (1.17) −1.81 (1.12) 0.11 (−0.20 to 0.43)
WHZ −0.93 (0.97) −0.95 (0.92) 0.20 (−0.05 to 0.46)
WAZ −1.55 (1.08) −1.62 (1.00) 0.20 (−0.06 to 0.47)
Adjusted
OR (95% CI)a
Stunted, n (%) 122 (37.8) 265 (44.5) 0.81 (0.61 to 1.07)
Wasted, n (%) 45 (13.9) 67 (11.2) 1.35 (0.90 to 2.04)
Underweight, n (%) 106 (32.8) 209 (35.1) 0.97 (0.72 to 1.29)
aAdjusted for: age, sex, breastfeeding status, log transformed annual family income, family structure, mother’s years of schooling, father’s years of schooling,








Fig. 1 Associations between vitamin-D level at baseline and HAZ score at baseline. The graphs were constructed using generalized additive
models in R, the solid line depicts the association of vitamin-D level at baseline and HAZ score at baseline. The shaded area spans the 95% confidence
interval of this association
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There may be deficiencies other growth-limiting
macro and micronutrients such as calcium, zinc, vitamin
–B12 etc. Poor quality of food i.e. lower proportion of
animal source protein may also contribute to poor
growth. The influence of vitamin D might be small in
the light of other growth limiting factors.
To our knowledge this is the first analysis to examine
the association between vitamin-D status and several do-
mains of the ASQ-3. The strengths of our study are that
the data are from a well conducted study with very low
attrition rates. [33] More comprehensive assessment
tools, such as the Bayley scales, or tools for social emo-
tional functioning, could have added a broader picture
of the children’s skills and abilities yielding different re-
sults. There was a need for follow up assessments since
6 months may not be sufficient to assess the associations
between vitamin- D status and development and growth.
Finally, more advanced neuroimaging techniques may
have identified unique changes to the developing brain
in early childhood that could have been linked to
vitamin-D deficiency.
Conclusion
The results from this analysis do not support that
vitamin-D deficiency in early childhood is important for
growth and neurodevelopment.
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Vitamin D status in early childhood is not
associated with cognitive development and
linear growth at 6–9 years of age in North
Indian children: a cohort study
Ranadip Chowdhury1,2* , Sunita Taneja1, Ingrid Kvestad3, Mari Hysing4, Nita Bhandari1 and Tor A. Strand2,5
Abstract
Background: Vitamin D is important for brain function and linear growth. Vitamin D deficiency during pregnancy
has been linked with impaired neurodevelopment during early childhood. However, there is limited evidence from
population-based studies on the long-term impact of vitamin D deficiency on cognitive development and linear
growth. The objective of the current analysis is to examine whether vitamin D deficiency during infancy and early
childhood is associated with cognitive development and linear growth measured in school age.
Methods: This is a follow-up study of a placebo-controlled trial among 1000 North Indian children 6–30 months of
age. We measured growth and neurodevelopment in 791 of these children when they were 6–9 years old.
Neurodevelopment was measured using the Wechsler Intelligence Scale for Children, 4th edition INDIA, the Crichton
Verbal Scale, NEPSY-II subtests, and the BRIEF 2. We categorized vitamin D concentrations during infancy and early
childhood according to the US Institute of Medicine’s recommendations; serum 25(OH)D < 12 ng/ml as deficient;
12–20 ng/ml as inadequate; > 20 ng/ml as sufficient. In multivariable regression models, adjusting for relevant
confounders, we estimated the association between vitamin D status, growth and neurodevelopmental outcomes.
Results: Among the 791 children, baseline vitamin D status was available for 716. Of these, 45.8% were vitamin D
deficient, 32.7% were inadequate, and 21.5% were sufficient. Vitamin D status was not associated with any of the
cognitive outcomes or linear growth [Adjusted β coefficient for height for age z-score between deficient and
sufficient children was − 0.06 (95% CI − 0.24 to 0.11)] at follow up.
Conclusion: Our findings do not support the notion that poor vitamin D status in early childhood is an important
limitation for cognitive development and linear growth.
Trial Registration: The trial was first registered at www.clinicaltrials.gov as NCT00717730 in July, 2008, and at
CTRI/2010/091/001090 in August, 2010 and then as CTRI/2016/11/007494 in November 2016.
Keywords: Vitamin D, Wechsler intelligence scale for children, 4th edition INDIA , Crichton verbal scale, A
developmental neuropsychological assessment II, The behavior rating inventory of executive function 2, Linear
growth, School age
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Background
Vitamin D deficiency is one of the most common micro-
nutrient deficiencies worldwide [1]. In the Indian sub-
continent, the prevalence of vitamin D deficiency is
estimated to be from 50 to 90% using an internationally
accepted reference value [2]. Vitamin D acts by binding
to the nuclear vitamin D receptors (VDR), which are
widely distributed throughout the human brain in most
neurons and some glial cells [3, 4]. Animal studies have
shown that vitamin D deficiency during pregnancy
causes extreme alterations in the brain at birth [5, 6].
This provides a biological plausibility for a link between
vitamin D status and neurodevelopment.
There is evidence from observational studies on the
association between vitamin D status during pregnancy
or cord blood vitamin D at birth with cognitive, lan-
guage, and behavioral development in different periods
of childhood [7–12]. Previously, we have shown that
vitamin D status was not associated with neurodevelop-
ment as measured by a brief screening tool, the Ages
and Stages Questionnaire 3rd edition (ASQ-3) during
early childhood [13]. The consequences of vitamin D de-
ficiency in early life on neurodevelopmental may not be-
come evident until later in childhood. Furthermore, the
predictive ability of early neurodevelopmental assess-
ments is poor, and cognitive assessments in school-aged
children have shown to be stable over time [14, 15]. We
measured vitamin D status in 1000 young North Indian
children and conducted a comprehensive assessment of
cognitive performance and growth approximately 6 years
later [16, 17]. This study gave us a unique opportunity
to explore the extent to which vitamin D deficiency dur-
ing early childhood is associated with impaired cognitive
development and linear growth at school age.
Methods
Study design and participants
We followed up children who previously participated in
a randomized double-blind placebo-controlled trial (n =
1000) on the effect of two recommended daily allow-
ances (RDA) of vitamin B12 and/or folic acid daily for 6
months in Delhi, North India [18]. The main outcome
of the study was incidence of infections. In September
2016, we approached all these children, and were able to
get in contact with 798 of whom 791 consented to par-
ticipate in the follow-up study. (Fig. 1) All families were
initially contacted by phone to be invited to participate
in the study. A physical visit was made to the family’s
address if no contact could be made. We requested the
families who had moved out of the study area to come
to the study clinic for 1 day. On the day of the assess-
ment, consent was taken from the children’s caregiver
Fig. 1 Participant Flow
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for the participation in the study and we gathered infor-
mation on socio-economic situation of the family such




We assessed cognitive development with the Wechsler
Intelligence Scale for Children, 4th edition INDIA, the
Crichton Verbal Scale, NEPSY-II subtests and the
BRIEF 2.
The Wechsler Intelligence Scale for Children 4th
edition (India) (WISC-IVINDIA) is an assessment tool
of intellectual ability in children validated for the In-
dian population with Indian norms [19]. We assessed
seven subtests (listed in the parenthesis) that were
summed up to three index scores; the Perceptual
Reasoning (Block design, Picture concept, Matrix
reasoning), Processing Speed (Symbol search, Letter-
number sequences) and Working Memory (Digit
span, Coding).
The Crichton Vocabulary Scales (CVS) assess verbal
skills in children 4 to 18 years through knowledge of
words [20]. The CVS has been translated to Hindi and
provides a standard score with Indian norms [21].
NEPSY-II is a neuropsychological test battery for chil-
dren aged 3 to 16 years with American norms [22].
Seven age-appropriate subtests were administered; In-
hibition and Design Fluency, Word Generation, Visuo-
motor Precision and Manual Motor Sequences, Affect
Recognition and Geometric Puzzles. No modifications
and cultural adjustments were necessary to perform the
tests in this setting.
The Behavior Rating Inventory of Executive Function
2nd edition (BRIEF 2) is a parent report questionnaire
for children 5 to 18 years assessing executive functions
in everyday life with American norms [23]. The scale
comprises three clinical indexes; the Behavior, Emotion
and Regulation Index, and an overall Global Executive
Composite. The questionnaire was translated and vali-
dated to Hindi in close collaboration with the developers
(PARiConnect).
Growth
Trained field supervisors measured weight and height
at follow up. Weight was measured to the nearest 50
g using a Digitron scales. Height was measured with
Seca 213 to the nearest 0.1 cm. Inter- and intra-
observer standardization exercises for weight and
height assessments were conducted before study initi-
ation for outcome ascertainment team; these are re-
peated every 3 months.
Analytical procedures
At baseline, 3 ml blood was collected into an evacuated
tube containing EDTA (BD, Franklin Lakes, NJ, USA)
from all children. Plasma was separated from the
whole blood by centrifugation at room temperature
(450 x g × 10 min), transferred into storage vials and
stored at − 20 °C until analysis. Plasma concentration
of vitamin-D was measured by quantitative electro-
chemiluminescence binding assay (Roche Diagnostics,
Mannheim, Germany) at the Department of Biochem-
istry, Christian Medical College, Vellore, India [24].
Plasma homocysteine (tHcy) was analyzed using com-
mercial kits (Abbott Park, IL, USA) [25]. Plasma con-
centrations of vitamin B12 and folate were determined
by microbiological assays using a chloramphenicol-
resistant strain of Lactobacillus casei and colistin
sulfate-resistant strain of Lactobacillus leichmannii,
respectivel y[26, 27]. Plasma soluble transferrin recep-
tor (sTfR) was analyzed using an immunoturbidimetric
assay [28].
Statistical analysis
Proportions, means (SD) or medians (IQR) were calcu-
lated for categorical and continuous variables by
vitamin-D status at baseline. We categorized vitamin
D status according to the US Institute of Medicine’s
recommendations; serum 25(OH)D < 12 ng/ml as ‘defi-
cient’; 12–20 ng/ml as ‘inadequate’; > 20 ng/ml as ‘suf-
ficient’ [29]. For the cognitive outcomes, we calculated
a combined WISC-IVINDIA and CVS z-score based on
converted z-scores for the three index scores in the
WISC-IVINDIA and the total CVS score. We also calcu-
lated a combined NEPSY-II z-score based on con-
verted z-scores in the seven subtests. For the BRIEF 2,
we used the overall Global Executive Composite score
in the analyses. Children’s height-for-age z-score
(HAZ) at follow up was calculated based on WHO
growth standards [30]. The wealth of an individual
was determined by a wealth index created using prin-
cipal component analysis based on assets owned by
the household [31]. Using the score from the principal
component analysis, the population was divided into
five equal wealth quintiles i.e. poorest, very poor, poor,
less poor and least poor.
We used multivariable linear regression to investigate
the association between vitamin D status at baseline and
the cognitive outcomes and HAZ score at follow up. We
used generalized linear model (GLM) with the gaussian
distribution family, and identity link function to calcu-
late beta-coefficients for the cognitive outcomes and the
HAZ scores. We used GLM with the poisson distribu-
tion family, and log link to calculate the relative risk
(RR) for stunting [32].
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Table 1 Demographic information and nutritional status of the 716 North Indian children at baseline (6 to 30 months) and follow







Child characteristics at baseline (6 to 30 months)
Boys, n (%) 85 (55.2) 125 (53.4) 161 (49.1)
Ever breastfed, n (%) 154 (100) 232 (99.1) 323 (98.5)
Growth Z scores, mean (sd)
Weight-for-height (WHZ) −0.9 (0.9) − 0.9 (0.9) − 0.8 (0.9)
Height-for-age (HAZ) −1.7 (1.1) − 1.6 (1.1) − 1.6 (1.2)
Weight-for-age (WAZ) − 1.6 (0.9) −1.5 (1) − 1.5 (1)
Wasted (<−2 WHZ) 18 (11.7) 28 (12) 34 (10.4)
Stunted (<−2 HAZ) 59 (38.3) 86 (36.7) 128 (39)
Underweight (<−2 WAZ) 47 (30.5) 77 (32.9) 105 (32)
Biomarkers:
Cobalamin, mean (sd) pmol/L 312.7 (186.7) 332.6 (215.3) 305.9 (175.2)
Cobalamin < 200 pmol/L, n (%) 47 (30.5) 72 (30.8) 106 (32.3)
Folate, mean (sd) nmol/L 16.7 (14.6) 16.1 (13.7) 14.9 (14.4)
Folate < 7.5 nmol/L, n (%) 48 (31.2) 69 (29.5) 115 (35.1)
Homocysteine, mean (sd) μmol/L 14.4 (8.8) 13.3 (6.7) 13.7 (7.3)
Homocysteine > 10 μmol/L, n (%) 104 (68.4) 144 (62.1) 204 (62.4)
Soluble transferrin receptor, mean (sd) nmol/L 4.3 (2.8) 4.4 (3.3) 4.7 (3.1)
Soluble transferrin receptor> 4.7 nmol/L, n (%) 40 (26) 76 (32.5) 111 (33.8)
Child characteristics at follow up (6 to 9 years)
Age follow up (yrs) mean (SD) 7.9 (0.6) 7.8 (0.6) 7.9 (0.6)
Schooling
No School, n (%) 3 (1.9) 6 (2.6) 4 (1.2)
Hindi medium, n (%) 61 (39.6) 88 (37.6) 129 (39.3)
English medium, n (%) 90 (58.4) 140 (59.8) 195 (59.4)
Family characteristics at follow up
Mothers years of schooling
No schooling, n (%) 54 (35.5) 65 (28) 76 (23.3)
Primary (1–5 years), n (%) 23 (15.1) 18 (7.8) 49 (15)
Middle (6–12 years), n (%) 65 (42.8) 123 (53) 153 (46.9)
Higher (> 12 years), n (%) 10 (6.6) 26 (11.2) 48 (14.7)
Fathers occupation
Government job or private services, n (%) 88 (57.1) 135 (57.9) 165 (50.8)
Self-employed, n (%) 31 (20.1) 56 (24) 95 (29.2)
Daily wager/farming, n (%) 29 (18.8) 31 (13.3) 52 (16)
No job/other, n (%) 6 (3.9) 11 (4.7) 13 (4)
Wealth Quintile
Poorest, n (%) 39 (25.3) 47 (20.1) 60 (18.3)
Very Poor, n (%) 36 (23.4) 38 (16.2) 65 (19.8)
Poor, n (%) 31 (20.1) 57 (24.4) 60 (18.3)
Less Poor, n (%) 32 (20.8) 43 (18.4) 69 (21)
Least Poor, n (%) 16 (10.4) 49 (20.9) 74 (22.6)
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We used a method of purposeful selection of covar-
iates to identify variables for the multivariable models
[33, 34]. We included in the multivariable models the
variables that changed the beta coefficient or relative
risk of the outcome variables by 20% from the uni-
variable models. We present the adjusted models, in-
cluding variables that were identified in the process.
The candidate variables for these models were age
and sex of the child, maternal and paternal years of
schooling, paternal occupation, wealth quintiles at fol-
low up and baseline log (base e) cobalamin, folate,
and total homocysteine concentration and the inter-
vention groups.
Statistical analyses were performed using STATA ver-
sion 15 (Stata Corporation, College Station, TX). We
used generalized additive models in the statistical soft-
ware R version 3.1.2 (The R Foundation for Statistical
Computing, Vienna, Austria) to explore nonlinear asso-
ciations between the plasma vitamin D concentration at
baseline and the combined WISC-IVINDIA and CVS z-
score, the combined NEPSY-II z-score and the Global
BRIEF-2 score at follow up after adjustment for potential
confounders [35].
Results
Of the 1000 children in the main study, 791 children
consented to participate in the follow-up study. Fig. 1
shows the flow of the participants. The demographic in-
formation and nutritional status of the children at
baseline and follow up are presented in Table 1. Baseline
vitamin D status was available for 716 children who con-
sented. Of these, 328 (45.8%) were deficient, 234 (32.7%)
were inadequate, and 154 (21.5%) sufficient [29]. The
mean (SD) and median (IQR) of vitamin D concentra-
tion at baseline were 14.6 (8.6) ng/ml and 12.8 (8.3–
18.7) ng/ml, respectively.
The estimates from both univariable and multivari-
able analyses comparing the combined WISC-
IVINDIA and CVS z-score, the combined NEPSY-II z-
score and the Global BRIEF-2 score between vitamin
D inadequate, deficient, and vitamin D sufficient
children are shown in Table 2. There were no sig-
nificant differences between the vitamin D sufficient
children, inadequate and deficient children on any of
the cognitive outcomes.
Table 3 shows the association between baseline vita-
min D status and linear growth at follow up. Of the
children, 15.8, 12.4 and 17.5% were stunted in the
vitamin D deficient, inadequate and sufficient group,
respectively. Vitamin D status was not associated with
the HAZ score or the proportion of children stunted
at follow up.
The association between vitamin D concentration at
baseline and the cognitive outcomes at follow up are
depicted in Fig. 2. The GAMs did not reveal any non-
linear associations between vitamin D level at baseline
and the combined WISC-IVINDIA and CVS z-score and
the Global BRIEF-2 score at follow up.
Table 2 The association between baseline Vitamin D status and cognitive scores at follow up in North Indian children 6 to 9 years
























0.03 (−0.17 to 0.23) −0.12 (−0.30 to 0.05) −0.01 (−0.21 to 0.19) −0.15 (−0.33 to 0.04) 0.21 (−2.10 to 2.48) 0.87 (−1.40 to 3.14)
Vitamin D
deficient
0.02 (− 0.16 to 0.22) − 0.13 (− 0.29 to 0.04) −0.02 (− 0.21 to 0.17) −0.16 (− 0.34 to 0.02) −1.10 (−3.21 to 1.05) −0.38 (− 2.53 to 1.77)
aadjusted for log folate, log soluble transferrin receptor and log homocysteine level at baseline, and the wealth index, paternal occupational status and maternal
education at follow-up and intervention group
Table 3 The association between baseline Vitamin D status and linear growth at follow up in North Indian children 6 to 9 years









Vitamin D sufficient Reference Reference
Vitamin D inadequate 0.06 (−0.13 to 0.26) −0.07 (− 0.26 to 0.12) 0.70 (0.42 to 1.20) 0.87 (0.50 to 1.50)
Vitamin D deficient 0.08
(−0.10 to 0.27)
−0.06 (− 0.24 to 0.11) 0.90 (0.57 to 1.44) 1.14 (0.70 to 1.86)
aadjusted for log folate, log soluble transferrin receptor and log homocysteine level, at baseline and the wealth index, paternal occupational status and maternal
education at follow-up and intervention group
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Discussion
We did not find any evidence for a link between early
vitamin D status and long-term cognition and linear
growth.
To our knowledge, this is the first study that has ex-
amined the relationship between vitamin D status in
early childhood and cognitive development at school
age. The findings from this study are in accordance with
findings from the same cohort when neurodevelopment
was measured in early childhood [13]. The findings are
also similar to those from a cohort study in India, where
vitamin D status in early childhood was not associated
with the gross motor functioning among school aged
children [36]. Studies that have examined the association
between cord blood vitamin D concentrations and neu-
rodevelopment measured in early and middle childhood
have shown mixed results [37, 38]. Furthermore, studies
that have examined the associations between vitamin D
Fig. 2 Association between baseline vitamin D level and the combined WISC IVINDIA and Crichton Vocabulary Scale (CVS) z-score, the combined
NEPSY II z scores and the BRIEF P Global Executive composite score at follow up in North Indian children 6 to 9 years. The graph was constructed
using generalized additive models in R, the solid line depicts the association of vitamin D level at baseline and Global BRIEF score at follow up.
The shaded area spans the 95% confidence interval of this association
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deficiency during pregnancy and neurodevelopment
during early and middle childhood have also shown
inconsistent results [7–12, 39]. Three studies found an
association between pregnancy vitamin D status and
neurodevelopment outcomes in children before 4 years
of age [8, 11, 38], while one study found marginal associ-
ations with language scores at 10 years of age [10]. The
inconsistencies are likely due to differences in the popu-
lations, the timing of vitamin D assessment during preg-
nancy, the use of different cut-offs for vitamin D
deficiency, age of the child at developmental assess-
ments, and the way potential confounders were handled.
The large sample size, the broad range of cognitive as-
sessments, many with Indian norms, and the timing of
the assessments at school age provide strengths to our
findings that early vitamin D status most likely is not
associated with cognitive function on long term.
We found no association between vitamin D status at
baseline and linear growth at follow up. There are similar
findings described in pre-school children in Nepal and in
uninfected HIV exposed infants in Africa [40, 41]. In con-
trast, low-birth-weight (1.8 to 2.5 kg) infants in India, who
received 1 RDA of vitamin D supplementation showed sig-
nificantly higher length and weight at 6 months of age com-
pared to those who received placebo [42]. Vitamin D helps
the growth plate cells to be more sensitive to growth hor-
mone action which plays an important role in linear growth
at school age [43]. Vitamin D also maintains bone health to
ensure normal calcium and phosphate levels in the blood
[44]. Thus, our findings of no association between vitamin
D deficiency and linear growth may be unexpected. A prob-
able explanation could be that the children have to be se-
verely deficient in vitamin D before it has consequences for
their bone growth. There may be deficiencies of other
growth-limiting macro and micronutrients such as calcium,
zinc, vitamin B12 that account for the variance of growth
between these study children. Furthermore, lower propor-
tion of animal source protein in food, may also contribute
to poor growth in this population [45]. The role of vitamin
D might thus be negligible in the light of other growth lim-
iting factors in this population.
Dietary sources of vitamin D are limited mainly to oily
fish, eggs, and fortified foods [46]. As most people in the
northern part of India are vegetarians, the predominant
dietary source of vitamin D among the study children
would be milk. Milk is rarely fortified with vitamin D in
India and the vitamin D content of unfortified milk is
very low (2 IU/100 mL). Prevalence of lactose intolerance
also contributes to vitamin D deficiency in this setting
[47]. Currently, there is no national program of vitamin
D supplementation for infants and children, but the In-
dian Academy of Pediatrics guidelines recommend daily
vitamin D supplementation in doses of 400 IU up to 1
year of age and 600 IU from 1 to 18 years of age [48].
The main strength of the study is that we measured vita-
min D status in a large sample of children during what is
considered a critical window for the brain development,
and measured the cognitive outcomes during a period
where valid and stable estimates can be obtained. The
study includes high quality and comprehensive assessment
of cognitive development, with the use of validated tests
with Indian norms. We were able to include 80% of the
children from the primary cohort after more than 5 years
with no significant differences between the children who
were included in the follow-up and not. An immunoassay
method was used to assess vitamin D concentration. The
immunoassay can underestimate serum 25(OH) D2 con-
centration compared to liquid chromatography-tandem
mass spectrometry (LC-MS/MS) [49].
Conclusion
The results from the current study do not support that
vitamin D status in early childhood is of importance for
long-term growth and cognition.
Abbreviations
BRIEF: Behavior rating inventory of executive function; CI: Confidence
interval; CVS: Crichton Verbal Scale; NEPSY: A developmental neuro
psychological assessment; RCT: Randomized controlled trial;
RDA: Recommended daily allowance; SD: Standard deviation; tHcy: Total
Homocysteine; WISC-IV INDIA: Wechsler intelligence scale for children, 4th
edition INDIA
Acknowledgements
We acknowledge the group of study psychologists and the coordinator who
performed the cognitive assessments with the children and their caregivers;
Farah Abbasi, Heena Chaudhary, Raqib Ali, Sugandhi Nagpal, Vaishali Panwar
and Shruti Bisht. We acknowledge the input from Ratnasamy Selvakumar,
Department of Biochemistry from Christian Medical College, Vellore, India for
biochemical analysis. The Society for Applied Studies acknowledges the core
support provided by the Department of Maternal, Newborn, Child and
Adolescent Health, World Health Organisation, Geneva (WHO Collaborating
Centre IND-158) and the Centre for Intervention Science in Maternal and
Child Health (RCN Project No. 223269), Centre for International Health,
University of Bergen (Norway). We also acknowledge Centre for Intervention
Science in Maternal and Child Health (CISMAC; project number 223269),
which is funded by the Research Council of Norway through its Centres of
Excellence scheme and the University of Bergen (UiB), Norway.
Authors’ contributions
RC, TS, ST, IK designed the research with contributions from all authors. RC
and TS did the statistical analysis with support from ST, IK, MH, and NB. RC
wrote the first draft. All authors contributed to the critical interpretation and
writing of the paper and saw and approved the final version.
Funding
The study was funded by the Thrasher Research Fund (grant no 02827) and
the Research Council of Norway (grant no. 172226 and 234495).
Availability of data and materials
Request for data pertaining to the current analysis may be sent to Dr. Sunita
Taneja (Email id: sunita.taneja@sas.org.in).
Ethics approval and consent to participate
The follow-up study was approved from the ethics committee of Society for
Applied Studies (India) and Norwegian Regional Committee for Medical and
Health Research Ethics (REK VEST). The consent form for the main trial also
sought permission from parents to store participating children’s blood
specimen for use in future research. All parents consented for the same.




The authors declare that they have no competing interests.
Author details
1Centre for Health Research and Development, Society for Applied Studies,
45, Kalu Sarai, New Delhi 110016, India. 2Department of Global Public Health
and Primary Care, Centre for International Health, University of Bergen,
Bergen, Norway. 3Regional Centre for Child and Youth Mental Health and
Child Welfare, West, NORCE Norwegian Research Center, Bergen, Norway.
4Department of Psychosocial Science, Faculty of Psychology, University of
Bergen, Bergen, Norway. 5Department of Research, Innlandet Hospital Trust,
Lillehammer, Norway.
Received: 22 October 2019 Accepted: 5 February 2020
References
1. Holick MF. Vitamin D: extraskeletal health. Rheum Dis Clin N Am. 2012;38:
141–60. https://doi.org/10.1016/j.rdc.2012.03.013.
2. Kamboj P, Dwivedi S, Toteja GS. Prevalence of hypovitaminosis D in India &
way forward. IJMR. 2018;48(5):548–56.
3. Pike JW, Meyer MB. The vitamin D receptor: new paradigms for the regulation
of gene expression by 1,25-dihydroxyvitamin D(3). Endocrinol Metab Clin N
Am. 2010;39(2):255–69. https://doi.org/10.1016/j.ecl.2010.02.007.
4. Kesby JP, Eyles DW, Burne TH, McGrath JJ. The effects of vitamin D on brain
development and adult brain function. Mol Cell Endocrinol. 2011;347(1–2):
121–7. https://doi.org/10.1016/j.yfrne.2012.07.001.
5. O’Loan J, Eyles DW, Kesby J, Ko P, McGrath JJ, Burne TH. Vitamin-D status
during various stages of pregnancy in the rat; its impact on development
and behaviour in adult offspring. Psychoneuroendocrinology. 2007;32:227–
34. https://doi.org/10.1016/j.psyneuen.2006.12.006.
6. Eyles D, Brown J, Mackay-Sim A, McGrath J, Feron F. Vitamin-D3 and brain
development. Neuroscience. 2003;118:641–53. https://doi.org/10.1016/
s0306-4522(03)00040-x.
7. Strom M, Halldorsson TI, Hansen S, Granström C, Maslova E, Petersen SB,
Cohen AS, Olsen SF. Vitamin D measured in maternal serum and offspring
neurodevelopmental outcomes: a prospective study with long-term follow-
up. Ann Nutr Metab. 2014;64:254–61. https://doi.org/10.1159/000365030.
8. Morales E, Guxens M, Llop S, Rodríguez-Bernal CL, Tardón A, Riaño I,
Ibarluzea J, Lertxundi N, Espada M, Rodriguez A. Circulating 25-
hydroxyvitamin D3 in pregnancy and infant neuropsychological
development. Pediatrics. 2012;130:e913–20. https://doi.org/10.1542/peds.
2011-3289.
9. Keim SA, Bodnar LM, Klebanoff MA. Maternal and cord blood 25(OH)-
vitamin D concentrations in relation to child development and
behaviour. Paediatr Perinat Epidemiol. 2014;28:434–44. https://doi.org/10.
1111/ppe.12135.
10. Whitehouse AJ, Holt BJ, Serralha M. Maternal serum vitamin D levels during
pregnancy and offspring neurocognitive development. Pediatrics. 2012;129:
485–93. https://doi.org/10.1542/peds.2011-2644.
11. Hanieh S, Ha TT, Simpson JA, Thuy TT, Khuong NC, Thoang DD, Tran TD,
Tuan T, Fisher J, Biggs BA. Maternal vitamin D status and infant outcomes in
rural Vietnam: a prospective cohort study. PLoS One. 2014;9:e99005. https://
doi.org/10.1371/journal.pone.0099005.
12. Brouwer-Brolsma EM, Vrijkotte TG, Feskens EJ. Maternal vitamin D
concentrations are associated with faster childhood reaction time and
response speed, but not with motor fluency and flexibility, at the age of 5–
6 years: the Amsterdam born children and their development (ABCD) study.
Br J Nutr. 2018;120(3):345–52. https://doi.org/10.1017/S0007114518001319.
13. Chowdhury R, Taneja S, Bhandari N, Kvestad I, Strand TA. Bhan MK. Vitamin-
D status and neurodevelopment and growth in young north Indian
children: a secondary data analysis. Nutr J, 2017; 16: 59 doi: https://doi.org/
10.1186/s12937-017-0285-y.
14. Månsson J, Stjernqvist K, Serenius F, Ådén U, Källén K. Agreement between
Bayley-III measurements and WISC-IV measurements in typically developing
children. J Psychoeduc Assess. 2018. https://doi.org/10.1177/
0734282918781431.
15. Schneider W, Niklas F, Schmiedeler S. Intellectual development from early
childhood to early adulthood: The impact of early IQ differences on stability
and change over time. Learn Individ Differ 2014;32:156–162. doi: https://doi.
org/https://doi.org/10.1016/j.lindif.2014.02.001.
16. Winje BA, Kvestad I, Krishnamachari S, Manji K, Taneja S, Bellinger DC, et al.
Does early vitamin B&lt;sub&gt;12&lt;/sub&gt; supplementation improve
neurodevelopment and cognitive function in childhood and into school
age: a study protocol for extended follow-ups from randomised controlled
trials in India and Tanzania. BMJ Open. 2018;8(2):e018962.
17. Chowdhury R, Taneja S, Bhandari N, Sinha B, Upadhyay RP, Bhan M, Strand
TA. Vitamin-D deficiency predicts infections in young north Indian children:
a secondary data analysis. PLoS One. 2017;12(3):e0170509. https://doi.org/10.
1371/journal.pone.0170509.
18. Taneja S, Strand TA, Kumar T, Mahesh M, Mohan S, Manger MS. Folic acid
and vitamin B-12 supplementation and common infections in 6-30-mo-old
children in India: a randomized placebo-controlled trial. Am J Clin Nutr.
2013;98(3):731–7. https://doi.org/10.3945/ajcn.113.059592.
19. Wechsler D. WISC-IV India. Wechsler intelligence scale for children - fourth
(India edition). New Delhi: Pearson; 2016.
20. Raven J, Rust J, Squire A. Manual for Coroured progressive matrices and
Crichton vocabulary scale. NCS Pearson Inc: UK; 2008.
21. Raven J, Rust J, Squire A. Raven’s Coloured Progressive Matrices and
Crichton Vocabulary Scales (Hindi Edition). Chennai, India: Pearson Clinical &
Talent Assessment; 2015.
22. Brooks BL, Sherman S, Strauss E. NEPSY-II: A developmental
neuropsychological assessment, second edition. 2010 Child Neuropsychol
16(1):80–101. https://doi.org/10.1080/09297040903146966.
23. Gioia GA, Isquith PK, Roth RM. Behavior Rating Inventory for Executive
Function. In: Kreutzer JS, DeLuca J, Caplan B, eds. Encyclopedia of Clinical
Neuropsychology. Cham: Springer International Publishing; 2018:532–8.
https://doi.org/10.1007/978-3-319-57111-9_1881.
24. Cobas E411 Vitamin-D Total Reagent Insert (06268668001V1). Roche
Diagnostics Web site. Available online: http://www.cobas.com/home/
product/clinical-and-immunochemistry-testing/elecsys-vitamin-d-total-assay.
html Accessed 17 April 2019.
25. Shipchandler MT, Moore EG. Rapid, fully automated measurement of plasma
homocyst (e) ine with the Abbott IMx analyzer. Clin Chem. 1995;41(7):991e4.
26. O'broin S, Kelleher B. Microbiological assay on microtitre plates of folate in
serum and red cells. J Clin Pathol. 1992;45(4):344e7.
27. Kelleher BP, Walshe KG, Scott JM, O'Broin SD. Microbiological assay for
vitamin B12 with use of a colistin-sulfate-resistant organism. Clin Chem.
1987;33(1):52e4.
28. Cotton F, Thiry P, Boeynaems J. Measurement of soluble transferrin receptor
by immunoturbidimetry and immunonephelometry. Clin Biochem. 2000;
33(4):263e7.
29. Spiro A, Buttriss JL. Vitamin D: An overview of vitamin D status and intake in
Europe. Nutr Bull 2014;39(4):322–350 doi:https://doi.org/10.1111/nbu.12108.
30. Onis M. WHO Child Growth Standards based on length/height, weight and
age. Acta Paediatr 2006; 95(S450): 76–85 doi: https://doi.org/https://doi.org/
10.1111/j.1651-2227.2006.tb02378.x.
31. International Institute for Population Sciences (IIPS) and Macro International.
National Family Health Survey (NFHS-4), 2015-16. Mumbai: International
Institute for Population Sciences (IIPS) and Macro International; 2015.
32. Zou G. A modified poisson regression approach to prospective studies
with binary data. Am J Epidemiol. 2004;159(7):702–6. https://doi.org/10.
1093/aje/kwh090.
33. Bursac Z, Gauss CH, Williams DK, Hosmer DW. Purposeful selection of
variables in logistic regression. Source Code Biol and Med. 2008;3:17.
https://doi.org/10.1186/1751-0473-3-17.
34. Hosmer DW, Lemeshow S, Sturdivant RX. Applied logistic regression. New
York: Wiley; 2013.
35. Wood SN. Modelling and smoothing parameter estimation with multiple
quadratic penalties. J Royal Stat Soc. 2000;62:413–428 doi: https://doi.org/
https://doi.org/10.1111/1467-9868.00240.
36. Filteau S, Rehman AM, Yousafzi A, Chugh R, Kaur M, Sachdev HPS, Trilok-
Kumar G. Association of vitamin D status, bone health and anthropometry,
with gross motor development and performance of school-aged Indian
children who were born at term low birth weight. BMJ Open. 2016;6:
e009268. https://doi.org/10.1136/bmjopen-2015-009268.
37. Zhu P, Tong SL, Hao JH, Tao RX, Huang K, Hu WB, Zhou QF, Jiang XM,
Tao FB. Cord blood vitamin D and neurocognitive development are
Chowdhury et al. Nutrition Journal           (2020) 19:14 Page 8 of 9
nonlinearly related in toddlers. J Nutr. 2015;145(6):1232–8. https://doi.
org/10.3945/jn.114.208801.
38. Gould JF, Anderson AJ, Yelland LN, Smithers LG, Skeaff CM, Zhou SJ, Gibson
RA, Makrides M. Association of cord blood vitamin-D with early childhood
growth and neurodevelopment. J Paediatr Child Health. 2017;53(1):75–83.
https://doi.org/10.1111/jpc.13308.
39. Darling AL, Rayman MP, Steer CD, Golding J, Lanham-New SA, Bath SC.
Association between maternal vitamin D status in pregnancy and
neurodevelopmental outcomesin childhood: results from the Avon
longitudinal study of parents and children (ALSPAC). Br J Nutr. 2017;117(12):
1682–92. https://doi.org/10.1017/S0007114517001398.
40. Avagyan D, Neupane SP, Gundersen TE, Madar AA. Vitamin D status in
preschool children in rural Nepal. Public Health Nutr. 2016;19(3):470–6.
https://doi.org/10.1017/S136898001500083X.
41. Sudfeld CR, Duggan C, Abound S, Kupka R, Manji KP, Kisenge R, Fawzi WW.
Vitamin D status is associated with mortality, morbidity, and growth failure
among a prospective cohort of HIV-infected and HIV-exposed Tanzanian
infants. J Nutr. 2015;145(1):121–7. https://doi.org/10.3945/jn.114.201566.
42. Kumar GT, Sachdev HS, Chellani H, Rehman AM, Singh V, Arora H, Filteau S.
Effect of weekly vitamin-D ements on mortality, morbidity, and growth of
low birthweight term infants in India up to age 6 months: randomised
controlled trial. BMJ. 2011;342:d2975. https://doi.org/10.1136/bmj.d2975.
43. Esposito S, Leonardi A, Lanciotti L, Cofini M, Muzi G, Penta L. Vitamin D and
growth hormone in children: a review of the current scientific knowledge. J
Transl Med. 2019;17(1):87.
44. Bikle DD. Vitamin D metabolism, mechanism of action, and clinical
applications. Chem Biol. 2014;21(3):319–29.
45. Eaton JC, Rothpletz-Puglia P, Dreker MR, Iannotti L, Lutter C, Kaganda J,
Rayco-Solon P. Effectiveness of provision of animal-source foods for
supporting optimal growth and development in children 6 to 59 months of
age. Cochrane Database of Systematic Reviews. 2019(2):CD012818. https://
doi.org/10.1002/14651858.CD012818.pub2.
46. Agarwal KS, Mughal MZ, Upadhyay P, Berry JL, Mawer EB, Puliyel JM. The
impact of atmospheric pollution on vitamin D status of infants and toddlers
in Delhi. India. 2002;87(2):111–3.
47. Ritu G, Gupta A. Vitamin-D deficiency in India: prevalence, causalities and
interventions. Nutrients. 2014;6:729–75. https://doi.org/10.3390/nu6020729.
48. Khadilkar A, Khadilkar V, Chinnappa J, Rathi N, Khadgawat R,
Balasubramanian S, et al. Prevention and treatment of vitamin D and
calcium deficiency in children and adolescents: Indian academy of
pediatrics (IAP) guidelines. Indian Pediatr. 2017;54:567–73.
49. Li L, Zeng Q, Yuan J, Xie Z. Performance evaluation of two immunoassays
for 25-hydroxyvitamin D. J Clin Biochem Nutr. 2016;58(3):186–92.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.




unication Division, UiB  /  Print: Skipnes Kom
m
unikasjon AS
uib.no
ISBN: 9788230859377 (print)
9788230840221 (PDF)
